Receptors	O
for	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-10	I-protein
and	I-protein
IL-6-type	I-protein
cytokines	I-protein
use	O
similar	O
signaling	O
mechanisms	O
for	O
inducing	O
transcription	O
through	O
IL-6	B-DNA
response	I-DNA
elements	I-DNA
.	O

The	O
cytoplasmic	B-protein
domain	I-protein
of	O
the	O
receptor	O
for	O
interleukin	B-protein
10	I-protein
(	O
IL-10R	B-protein
)	O
contains	O
two	O
box	B-protein
3	I-protein
sequence	I-protein
motifs	I-protein
that	O
have	O
been	O
identified	O
in	O
the	O
signal-transducing	B-protein
receptor	I-protein
subunits	I-protein
for	O
IL-6-type	B-protein
cytokines	I-protein
and	O
noted	O
to	O
be	O
required	O
for	O
activating	O
STAT3	B-protein
and	O
inducing	O
transcription	O
through	O
IL-6-responsive	B-DNA
elements	I-DNA
.	O

To	O
determine	O
whether	O
the	O
IL-10R	B-protein
has	O
signaling	O
functions	O
similar	O
to	O
IL-6R	B-protein
in	O
cells	O
normally	O
expressing	O
these	O
receptors	O
,	O
leukocytes	B-cell_type
of	O
the	O
B-	B-cell_type
,	I-cell_type
T-	I-cell_type
,	I-cell_type
and	I-cell_type
NK-cell	I-cell_type
lineages	I-cell_type
were	O
treated	O
with	O
either	O
cytokine	O
.	O

Both	O
cytokines	B-protein
activated	O
factors	O
that	O
bound	O
to	O
the	O
sis-inducible	B-DNA
element	I-DNA
and	O
included	O
STAT1	B-protein
and	O
STAT3	B-protein
.	O

The	O
cell	O
response	O
to	O
IL-10	B-protein
characteristically	O
differed	O
from	O
that	O
to	O
IL-2/IL-15	B-protein
,	O
IL-4	B-protein
,	O
and	O
interferon	B-protein
gamma	I-protein
.	O

The	O
signaling	O
capabilities	O
of	O
the	O
IL-10R	B-protein
for	O
activating	O
specific	O
STAT	B-protein
proteins	I-protein
and	O
inducing	O
gene	O
transcription	O
were	O
defined	O
by	O
reconstitution	O
of	O
receptor	O
functions	O
in	O
transfected	B-cell_line
tissue	I-cell_line
culture	I-cell_line
cells	I-cell_line
.	O

COS-1	B-cell_line
cells	I-cell_line
,	O
co-expressing	O
the	O
human	O
IL-10R	B-protein
and	O
individual	O
STAT	B-protein
proteins	I-protein
,	O
confirmed	O
a	O
preference	O
of	O
the	O
IL-10R	B-protein
for	O
STAT3	B-protein
and	O
STAT1	B-protein
.	O

Unlike	O
many	O
hematopoietin	B-protein
receptors	I-protein
,	O
the	O
IL-10R	B-protein
did	O
not	O
detectably	O
activate	O
STAT5	B-protein
.	O

The	O
IL-10R	B-protein
,	O
together	O
with	O
reporter	O
gene	O
constructs	O
containing	O
different	O
IL-6-responsive	B-DNA
gene	I-DNA
elements	I-DNA
,	O
reconstituted	O
in	O
hepatoma	B-cell_type
cells	I-cell_type
an	O
induction	O
of	O
transcription	O
by	O
IL-10	B-protein
that	O
was	O
comparable	O
to	O
that	O
by	O
IL-6	B-protein
.	O

This	O
regulation	O
could	O
not	O
be	O
appreciably	O
modified	O
by	O
enhanced	O
expression	O
of	O
STAT	B-protein
proteins	I-protein
.	O

The	O
similar	O
actions	O
of	O
IL-10R	B-protein
and	O
IL-6R	B-protein
on	O
the	O
induction	O
of	O
endogenous	O
IL-6-responsive	B-DNA
genes	I-DNA
were	O
demonstrated	O
in	O
hepatoma	B-cell_type
cells	I-cell_type
stably	O
expressing	O
the	O
IL-10R	B-protein
.	O

These	O
receptor	O
functions	O
required	O
the	O
presence	O
of	O
the	O
box	B-protein
3	I-protein
motifs	I-protein
,	O
as	O
shown	O
by	O
the	O
analysis	O
of	O
the	O
mouse	O
IL-10R	B-protein
constructs	O
containing	O
progressively	B-protein
truncated	I-protein
cytoplasmic	I-protein
domains	I-protein
.	O

The	O
data	O
demonstrate	O
that	O
the	O
IL-10R	B-protein
,	O
unlike	O
other	O
members	O
of	O
the	O
interferon	O
receptor	O
family	O
,	O
is	O
highly	O
effective	O
in	O
recruiting	O
the	O
signaling	O
pathways	O
of	O
IL-6-type	B-protein
cytokine	I-protein
receptors	I-protein
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

24	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

13968-13975	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Receptors	NULL
for	NULL
Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
and	NULL
IL-6-type	NULL
Cytokines	NULL
Use	NULL
Similar	NULL
Signaling	NULL
Mechanisms	NULL
for	NULL
Inducing	NULL
Transcription	NULL
through	NULL
IL-6	NULL
Response	NULL
Elements*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
24	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
6	NULL
,	NULL
1996	NULL
)	NULL
Chun-Fai	NULL
Lai	NULL
}	NULL
,	NULL
Juergen	NULL
Rippergert§	NULL
,	NULL
Karen	NULL
K.	NULL
Morellat	NULL
,	NULL
Jesper	NULL
Teresa	NULL
S.	NULL
Hawley|	NULL
,	NULL
William	NULL
E.	NULL
Carson	NULL
,	NULL
Tomasz	NULL
Kordula**	NULL
,	NULL
Michael	NULL
A.	NULL
Caligiurit	NULL
,	NULL
Robert	NULL
G.	NULL
Hawley	NULL
}	NULL
,	NULL
Georg	NULL
H.	NULL
Fey§	NULL
,	NULL
and	NULL
Heinz	NULL
Baumann	NULL
?	NULL

$	NULL
#	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
and	NULL
(	NULL
Medicine	NULL
and	NULL
Surgery	NULL
,	NULL
Roswell	NULL
Park	NULL
Cancer	NULL
Institute	NULL
,	NULL
Buffalo	NULL
,	NULL
New	NULL
York	NULL
14263	NULL
,	NULL
§Friedrich-Alexander	NULL
University	NULL
,	NULL
D-91068	NULL
Erlangen	NULL
,	NULL
Germany	NULL
,	NULL
Oncology	NULL
Research	NULL
Laboratories	NULL
,	NULL
The	NULL
Toronto	NULL
Hospital	NULL
,	NULL
Toronto	NULL
,	NULL
Ontario	NULL
M5G	NULL
2M1	NULL
,	NULL
Canada	NULL
,	NULL
and	NULL
the	NULL
**Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
Georgia	NULL
,	NULL
Athens	NULL
,	NULL
Georgia	NULL
30602	NULL
The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
interleukin	NULL
10	NULL
(	NULL
IL-10R	NULL
)	NULL
contains	NULL
two	NULL
box	NULL
3	NULL
sequence	NULL
motifs	NULL
that	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
signal-transducing	NULL
receptor	NULL
subunits	NULL
for	NULL
IL-6-type	NULL
cytokines	NULL
and	NULL
noted	NULL
to	NULL
be	NULL
required	NULL
for	NULL
activating	NULL
STAT3	NULL
and	NULL
inducing	NULL
transcription	NULL
through	NULL
IL-6-responsive	NULL
elements	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
IL-10R	NULL
has	NULL
signaling	NULL
functions	NULL
similar	NULL
to	NULL
IL-6R	NULL
in	NULL
cells	NULL
normally	NULL
expressing	NULL
these	NULL
receptors	NULL
,	NULL
leukocytes	NULL
of	NULL
the	NULL
B-	NULL
,	NULL
T-	NULL
,	NULL
and	NULL
NK-cell	NULL
lineages	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
cytokine	NULL
.	NULL

Both	NULL
cytokines	NULL
activated	NULL
factors	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
sis-inducible	NULL
element	NULL
and	NULL
included	NULL
STAT1	NULL
and	NULL
STAT3	NULL
.	NULL

The	NULL
cell	NULL
response	NULL
to	NULL
IL-10	NULL
characteristically	NULL
differed	NULL
from	NULL
that	NULL
to	NULL
IL-2/IL-15	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
interferon	NULL
y	NULL
.	NULL

The	NULL
signaling	NULL
capabilities	NULL
of	NULL
the	NULL
IL-10R	NULL
for	NULL
activating	NULL
specific	NULL
STAT	NULL
proteins	NULL
and	NULL
inducing	NULL
gene	NULL
transcription	NULL
were	NULL
defined	NULL
by	NULL
reconstitution	NULL
of	NULL
receptor	NULL
functions	NULL
in	NULL
transfected	NULL
tissue	NULL
culture	NULL
cells	NULL
.	NULL

COS-1	NULL
cells	NULL
,	NULL
co-expressing	NULL
the	NULL
human	NULL
IL-10R	NULL
and	NULL
individual	NULL
STAT	NULL
proteins	NULL
,	NULL
confirmed	NULL
a	NULL
preference	NULL
of	NULL
the	NULL
IL-10R	NULL
for	NULL
STAT3	NULL
and	NULL
STAT1	NULL
.	NULL

Unlike	NULL
many	NULL
hematopoietin	NULL
receptors	NULL
,	NULL
the	NULL
IL-10R	NULL
did	NULL
not	NULL
detectably	NULL
activate	NULL
STAT5	NULL
.	NULL

The	NULL
IL-10R	NULL
,	NULL
together	NULL
with	NULL
reporter	NULL
gene	NULL
constructs	NULL
containing	NULL
different	NULL
IL-6-responsive	NULL
gene	NULL
elements	NULL
,	NULL
reconstituted	NULL
in	NULL
hepatoma	NULL
cells	NULL
an	NULL
induction	NULL
of	NULL
transcription	NULL
by	NULL
IL-10	NULL
that	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
by	NULL
IL-6	NULL
.	NULL

This	NULL
regulation	NULL
could	NULL
not	NULL
be	NULL
appreciably	NULL
modified	NULL
by	NULL
enhanced	NULL
expression	NULL
of	NULL
STAT	NULL
proteins	NULL
.	NULL

The	NULL
similar	NULL
actions	NULL
of	NULL
IL-10R	NULL
and	NULL
IL-6R	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
endogenous	NULL
IL-6-responsive	NULL
genes	NULL
were	NULL
demonstrated	NULL
in	NULL
hepatoma	NULL
cells	NULL
stably	NULL
expressing	NULL
the	NULL
IL-10R	NULL
.	NULL

These	NULL
receptor	NULL
functions	NULL
required	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
box	NULL
3	NULL
motifs	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
IL-10R	NULL
constructs	NULL
containing	NULL
progressively	NULL
truncated	NULL
cytoplasmic	NULL
domains	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
IL-10R	NULL
,	NULL
unlike	NULL
other	NULL
members	NULL
of	NULL
the	NULL
interferon	NULL
receptor	NULL
family	NULL
,	NULL
is	NULL
highly	NULL
effective	NULL
in	NULL
recruiting	NULL
the	NULL
signaling	NULL
pathways	NULL
of	NULL
IL-6-type	NULL
cytokine	NULL
receptors	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
CA26122	NULL
(	NULL
to	NULL
H	NULL
.	NULL

B	NULL
.	NULL
)	NULL

and	NULL
Grant	NULL
4510	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
Canada	NULL
(	NULL
to	NULL
R.	NULL
G.	NULL
H.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.8.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
}	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
716-845-4587	NULL
;	NULL
Fax	NULL
:	NULL
716-845-8389	NULL
;	NULL
E-mail	NULL
:	NULL
baumann	NULL
@	NULL
sc3101	NULL
.	NULL

med	NULL
.	NULL

buffalo.edu	NULL
.	NULL

Interleukin	NULL
10	NULL
(	NULL
IL-10	NULL
)	NULL
,	NULL
*	NULL
like	NULL
IL-4	NULL
,	NULL
is	NULL
classified	NULL
as	NULL
an	NULL
anti-inflammatory	NULL
cytokine	NULL
based	NULL
on	NULL
its	NULL
suppressing	NULL
action	NULL
on	NULL
the	NULL
production	NULL
of	NULL
``	NULL
pro-inflammatory	NULL
mediators	NULL
``	NULL
and	NULL
its	NULL
contribution	NULL
to	NULL
resolve	NULL
inflammatory	NULL
reactions	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
IL-10	NULL
and	NULL
IL-4	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
the	NULL
same	NULL
physiological	NULL
process	NULL
and	NULL
have	NULL
common	NULL
target	NULL
cells	NULL
such	NULL
as	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
,	NULL
their	NULL
mechanism	NULL
of	NULL
actions	NULL
appears	NULL
to	NULL
be	NULL
substantially	NULL
different	NULL
.	NULL

The	NULL
IL-10R	NULL
is	NULL
structurally	NULL
related	NULL
to	NULL
IFN	NULL
receptors	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
IL-4R	NULL
belongs	NULL
to	NULL
the	NULL
family	NULL
of	NULL
hematopoietin	NULL
receptors	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Upon	NULL
ligand	NULL
binding	NULL
,	NULL
the	NULL
IL-10R	NULL
forms	NULL
oligomeric	NULL
complexes	NULL
(	NULL
6	NULL
)	NULL
.	NULL

As	NULL
noted	NULL
for	NULL
the	NULL
IFN	NULL
@	NULL
/BR	NULL
,	NULL
IL-10R	NULL
action	NULL
involves	NULL
the	NULL
stimulation	NULL
of	NULL
JAK1	NULL
and	NULL
TYK2	NULL
,	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
STAT	NULL
's	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
sequences	NULL
such	NULL
as	NULL
IFNy	NULL
activator	NULL
site	NULL
(	NULL
activating	NULL
sequence	NULL
)	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiated	NULL
gene	NULL
functions	NULL
by	NULL
IL-10	NULL
required	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
IL-10R	NULL
(	NULL
11	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
functional	NULL
IL-4R	NULL
consists	NULL
of	NULL
the	NULL
hetero-meric	NULL
complex	NULL
of	NULL
IL-4Ra	NULL
and	NULL
IL-2Ry	NULL
,	NULL
signals	NULL
via	NULL
JAK1	NULL
and	NULL
JAK3	NULL
,	NULL
and	NULL
preferentially	NULL
activates	NULL
STAT6	NULL
(	NULL
12	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
signal	NULL
transduction	NULL
may	NULL
partially	NULL
explain	NULL
the	NULL
difference	NULL
in	NULL
regulation	NULL
of	NULL
target	NULL
genes	NULL
seen	NULL
in	NULL
IL-10-	NULL
and	NULL
IL-4-responsive	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
signaling	NULL
of	NULL
the	NULL
IL-10R	NULL
with	NULL
that	NULL
of	NULL
IL-6R	NULL
and	NULL
characterized	NULL
the	NULL
gene-regulatory	NULL
action	NULL
of	NULL
the	NULL
IL-10R	NULL
by	NULL
its	NULL
reconstitution	NULL
in	NULL
heterologous	NULL
cell	NULL
systems	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
the	NULL
IL-10R	NULL
has	NULL
a	NULL
strong	NULL
preference	NULL
for	NULL
STAT3	NULL
and	NULL
exerts	NULL
a	NULL
transcriptional	NULL
induction	NULL
via	NULL
gene	NULL
regulatory	NULL
elements	NULL
that	NULL
is	NULL
highly	NULL
similar	NULL
to	NULL
that	NULL
mediated	NULL
by	NULL
the	NULL
IL-6R	NULL
or	NULL
other	NULL
box	NULL
3	NULL
motif-containing	NULL
hematopoietin	NULL
receptors	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells-HepG2	NULL
and	NULL
COS-1	NULL
cells	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Highly	NULL
purified	NULL
(	NULL
>	NULL
95	NULL
%	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
)	NULL
T-cells	NULL
were	NULL
prepared	NULL
from	NULL
fresh	NULL
human	NULL
blood	NULL
using	NULL
immunomagnetic	NULL
bead	NULL
depletion	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

CLL	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
blood	NULL
of	NULL
patients	NULL
with	NULL
a	NULL
proven	NULL
diagnosis	NULL
of	NULL
CLL	NULL
(	NULL
median	NULL
93	NULL
%	NULL
CD5+CD19+	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
)	NULL
and	NULL
then	NULL
stored	NULL
.	NULL

Upon	NULL
thawing	NULL
,	NULL
six	NULL
specimens	NULL
had	NULL
100	NULL
%	NULL
viability	NULL
by	NULL
vital	NULL
dye	NULL
exclusion	NULL
,	NULL
and	NULL
one	NULL
specimen	NULL
had	NULL
75	NULL
%	NULL
viability	NULL
.	NULL

The	NULL
NK-92	NULL
cell	NULL
line	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Hans	NULL
G.	NULL
Klingermann	NULL
(	NULL
Vancouver	NULL
,	NULL
British	NULL
Columbia	NULL
)	NULL
and	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
1	NULL
ng/ml	NULL
IL-2	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
R	NULL
,	NULL
receptor	NULL
;	NULL
RE	NULL
,	NULL
response	NULL
element	NULL
;	NULL
a	NULL
,	NULL
-MG	NULL
,	NULL
,	NULL
-macroglobulin	NULL
;	NULL
APP	NULL
,	NULL
acute	NULL
phase	NULL
plasma	NULL
protein	NULL
;	NULL
CLL	NULL
,	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
;	NULL
HRRE	NULL
,	NULL
hematopoietin	NULL
receptor	NULL
response	NULL
element	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
SIE	NULL
,	NULL
sis-inducible	NULL
element	NULL
;	NULL
SPT-3	NULL
,	NULL
serine	NULL
protease	NULL
inhibitor-3	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

13968	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
IL-10	NULL
Receptor	NULL
Signaling	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
;	NULL
specific	NULL
activity	NULL
1.53	NULL
x	NULL
10	NULL
``	NULL
units/mg	NULL
)	NULL
.	NULL

Leukocytes	NULL
were	NULL
maintained	NULL
for	NULL
2	NULL
h	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
from	NULL
established	NULL
lines	NULL
for	NULL
16	NULL
h	NULL
,	NULL
in	NULL
cytokine-	NULL
and	NULL
serum-free	NULL
medium	NULL
.	NULL

Depending	NULL
upon	NULL
the	NULL
experimental	NULL
settings	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
to	NULL
24	NULL
h	NULL
with	NULL
serum-free	NULL
medium	NULL
containing	NULL
100	NULL
ng/ml	NULL
purified	NULL
recombinant	NULL
human	NULL
IL-10	NULL
(	NULL
Schering-Plough	NULL
Research	NULL
Institute	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
Genetics	NULL
Institute	NULL
)	NULL
,	NULL
oncostatin	NULL
M	NULL
,	NULL
LIF	NULL
,	NULL
G-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
IL-15	NULL
(	NULL
Immunex	NULL
Corp.	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
Sandoz	NULL
,	NULL
Basel	NULL
)	NULL
,	NULL
IFNy	NULL
(	NULL
Genentech	NULL
)	NULL
,	NULL
or	NULL
IL-2	NULL
(	NULL
Cetus	NULL
)	NULL
,	NULL
or	NULL
5	NULL
ng/ml	NULL
IL-18	NULL
(	NULL
Immunex	NULL
Corp.	NULL
)	NULL
.	NULL

The	NULL
cytokine	NULL
concentrations	NULL
and	NULL
length	NULL
of	NULL
treatments	NULL
have	NULL
been	NULL
determined	NULL
previously	NULL
to	NULL
yield	NULL
maximal	NULL
response	NULL
,	NULL
i.e	NULL
.	NULL

activation	NULL
of	NULL
STAT	NULL
's	NULL
,	NULL
induction	NULL
of	NULL
genes	NULL
,	NULL
and	NULL
stimulation	NULL
of	NULL
plasma	NULL
protein	NULL
secretion	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
C	NULL
and	NULL
D	NULL
as	NULL
an	NULL
example	NULL
)	NULL
.	NULL

Plasmids-Expression	NULL
vectors	NULL
encoding	NULL
human	NULL
IL-10R	NULL
(	NULL
4	NULL
)	NULL
,	NULL
mouse	NULL
IL-10R	NULL
(	NULL
full-length	NULL
and	NULL
mutants	NULL
with	NULL
progressive	NULL
carboxyl-terminal	NULL
truncations	NULL
,	NULL
A483-559	NULL
,	NULL
A4883-559	NULL
,	NULL
A402-559	NULL
,	NULL
and	NULL
A380-559	NULL
;	NULL
Ref	NULL
.	NULL

11	NULL
)	NULL
,	NULL
G-CSFR	NULL
(	NULL
isoform	NULL
25.1	NULL
;	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
,	NULL
IL-3Ra	NULL
(	NULL
19	NULL
)	NULL
,	NULL
IL-3R	NULL
$	NULL
8	NULL
(	NULL
20	NULL
)	NULL
,	NULL
rat	NULL
STAT1a	NULL
,	NULL
STAT3	NULL
«	NULL
(	NULL
15	NULL
)	NULL
,	NULL
STAT5B	NULL
,	NULL
STAT5BA40C	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
human	NULL
STAT6	NULL
(	NULL
12	NULL
)	NULL
were	NULL
used	NULL
for	NULL
transfection	NULL
experiments	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
was	NULL
tested	NULL
with	NULL
the	NULL
following	NULL
established	NULL
CAT	NULL
reporter	NULL
gene	NULL
constructs	NULL
containing	NULL
either	NULL
tandem	NULL
oligomers	NULL
of	NULL
isolated	NULL
response	NULL
elements	NULL
:	NULL
pIL-GRE-CAT	NULL
and	NULL
pHRRE-CAT	NULL
(	NULL
16	NULL
,	NULL
23	NULL
)	NULL
,	NULL
or	NULL
promoters	NULL
of	NULL
the	NULL
following	NULL
liver	NULL
genes	NULL
encoding	NULL
acute	NULL
phase	NULL
plasma	NULL
proteins	NULL
(	NULL
APPs	NULL
)	NULL
that	NULL
are	NULL
known	NULL
to	NULL
be	NULL
responsive	NULL
to	NULL
IL-6	NULL
:	NULL
2700	NULL
bp	NULL
of	NULL
the	NULL
rat	NULL
a	NULL
,	NULL
-macroglobulin	NULL
(	NULL
a	NULL
«	NULL
,	NULL
-MG	NULL
)	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
,	NULL
1020	NULL
bp	NULL
and	NULL
148	NULL
bp	NULL
of	NULL
the	NULL
rat	NULL
serine	NULL
proteinase	NULL
inhibitor-3	NULL
(	NULL
SPT-3	NULL
)	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
219	NULL
bp	NULL
of	NULL
the	NULL
human	NULL
C-reactive	NULL
protein	NULL
(	NULL
CRP	NULL
)	NULL
gene	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Transfection-COS-1	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
27	NULL
)	NULL
with	NULL
DNA	NULL
mixtures	NULL
containing	NULL
1	NULL
ug/ml	NULL
expression	NULL
vector	NULL
for	NULL
receptors	NULL
and	NULL
3	NULL
pg/ml	NULL
expression	NULL
for	NULL
STAT	NULL
's	NULL
.	NULL

Transfected	NULL
cultures	NULL
were	NULL
subdivided	NULL
and	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
isoforms	NULL
by	NULL
15	NULL
min	NULL
cytokine	NULL
treatment	NULL
as	NULL
described	NULL
(	NULL
21	NULL
,	NULL
28	NULL
)	NULL
.	NULL

HepG2	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
(	NULL
28	NULL
)	NULL
using	NULL
DNA	NULL
mixture	NULL
containing	NULL
CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
(	NULL
15	NULL
ug/ml	NULL
)	NULL
,	NULL
expression	NULL
vector	NULL
for	NULL
receptors	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
and	NULL
for	NULL
STAT	NULL
's	NULL
(	NULL
1-5	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
pIE-MUP	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
pSV-B-galactosidase	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
as	NULL
internal	NULL
normalization	NULL
markers	NULL
.	NULL

Subcultures	NULL
were	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
cytokines	NULL
,	NULL
extracted	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
CAT	NULL
activity	NULL
following	NULL
standard	NULL
procedures	NULL
(	NULL
16	NULL
,	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
normalized	NULL
values	NULL
for	NULL
CAT	NULL
activity	NULL
were	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
untreated	NULL
control	NULL
in	NULL
each	NULL
experimental	NULL
series	NULL
(	NULL
=1.0	NULL
)	NULL
.	NULL

Cell	NULL
cultures	NULL
transfected	NULL
with	NULL
bacterial	NULL
B-galactosidase	NULL
gene	NULL
were	NULL
stained	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
strongly	NULL
positive	NULL
cells	NULL
was	NULL
determined	NULL
in	NULL
randomly	NULL
chosen	NULL
areas	NULL
on	NULL
the	NULL
culture	NULL
dish	NULL
(	NULL
containing	NULL
between	NULL
250	NULL
ando	NULL
390	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
transient	NULL
transfection	NULL
protocol	NULL
for	NULL
HepG2	NULL
cells	NULL
yielded	NULL
high	NULL
expressing	NULL
transfectants	NULL
that	NULL
amounted	NULL
to	NULL
2.1	NULL
+	NULL
2.4	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
(	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

,	NULL
n	NULL
=	NULL
50	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
HepG2	NULL
Cells	NULL
Stably	NULL
Expressing	NULL
the	NULL
Human	NULL
IL-10R-A	NULL
retroviral	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
human	NULL
IL-10R	NULL
(	NULL
MSCV-hIL-10R	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
2200-bp	NULL
XhoI	NULL
fragment	NULL
of	NULL
the	NULL
hIL-10R	NULL
cDNA	NULL
(	NULL
4	NULL
)	NULL
into	NULL
the	NULL
XAol	NULL
site	NULL
of	NULL
MSCVneoEB	NULL
carrying	NULL
the	NULL
bacterial	NULL
neo	NULL
gene	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Replication-defective	NULL
recombinant	NULL
MSCV-hIL-10R	NULL
virus	NULL
with	NULL
amphotropic	NULL
host	NULL
range	NULL
was	NULL
produced	NULL
from	NULL
stably	NULL
transduced	NULL
PA317	NULL
packaging	NULL
cells	NULL
(	NULL
Ref	NULL
.	NULL

30	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
CRL	NULL
9078	NULL
)	NULL
generated	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
by	NULL
infection	NULL
with	NULL
virus	NULL
harvested	NULL
from	NULL
transiently	NULL
transfected	NULL
GP+E-86	NULL
ecotropic	NULL
packaging	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
medium	NULL
with	NULL
4.5	NULL
g/liter	NULL
glucose	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Virus-containing	NULL
supernatant	NULL
was	NULL
collected	NULL
from	NULL
confluent	NULL
cultures	NULL
24	NULL
h	NULL
after	NULL
medium	NULL
change	NULL
and	NULL
filtered	NULL
through	NULL
a	NULL
0.45-um	NULL
membrane	NULL
.	NULL

The	NULL
virus	NULL
titer	NULL
on	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
was	NULL
1	NULL
x	NULL
10	NULL
``	NULL
G418-resistant	NULL
colony-forming	NULL
units/ml	NULL
.	NULL

The	NULL
virus-containing	NULL
medium	NULL
was	NULL
added	NULL
to	NULL
monolayers	NULL
of	NULL
HepG2	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
8	NULL
ug/ml	NULL
Polybrene	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
12	NULL
h.	NULL
The	NULL
infected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
containing	NULL
1	NULL
mg/ml	NULL
G418	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
infection	NULL
was	NULL
repeated	NULL
twice	NULL
on	NULL
the	NULL
same	NULL
cell	NULL
population	NULL
after	NULL
3	NULL
and	NULL
6	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
with	NULL
vector	NULL
integration	NULL
were	NULL
selected	NULL
by	NULL
increasing	NULL
G418	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
to	NULL
2	NULL
mg/ml	NULL
.	NULL

The	NULL
proliferating	NULL
cells	NULL
recovered	NULL
after	NULL
4	NULL
weeks	NULL
of	NULL
selection	NULL
(	NULL
termed	NULL
IL-10R-HepG2	NULL
cells	NULL
)	NULL
were	NULL
used	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
IL-10R	NULL
functions	NULL
.	NULL

EMSA	NULL
,	NULL
Western	NULL
Blot	NULL
,	NULL
and	NULL
Northern	NULL
Blot-Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
applied	NULL
to	NULL
EMSA	NULL
as	NULL
described	NULL
(	NULL
83	NULL
)	NULL
.	NULL

The	NULL
23-bp	NULL
high	NULL
affinity	NULL
SIEm67	NULL
(	NULL
5'-GATCTGATTACGGGAAATG-3	NULL
,	NULL
Ref	NULL
.	NULL

33	NULL
)	NULL
end-labeled	NULL
with	NULL
°°P	NULL
served	NULL
as	NULL
substrate	NULL
for	NULL
STAT1	NULL
,	NULL
-3	NULL
,	NULL
and	NULL
-4	NULL
,	NULL
and	NULL
the	NULL
40-bp	NULL
TB-2	NULL
(	NULL
a	NULL
tandem	NULL
dimer	NULL
of	NULL
the	NULL
``	NULL
IL-6RE	NULL
``	NULL
/APRE	NULL
of	NULL
the	NULL
rat	NULL
a	NULL
,	NULL
-MG	NULL
gene	NULL
;	NULL
5'-GAT-CATCCTTCTGGGAATTCTGATATCCTTCTGGGAATTCTGGATC-3	NULL
'	NULL
,	NULL
Ref	NULL
.	NULL

35	NULL
)	NULL
as	NULL
substrate	NULL
for	NULL
STAT1	NULL
,	NULL
-5	NULL
,	NULL
and	NULL
-6	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Anti-STAT3	NULL
(	NULL
C-20	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-STAT1	NULL
(	NULL
anti-ISGF-3	NULL
,	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
,	NULL
and	NULL
control	NULL
antibodies	NULL
(	NULL
Cappel	NULL
)	NULL
were	NULL
used	NULL
for	NULL
supershift	NULL
assay	NULL
.	NULL

Extracts	NULL
from	NULL
HepG2	NULL
and	NULL
H-35	NULL
cells	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
IL-6	NULL
were	NULL
included	NULL
as	NULL
standard	NULL
for	NULL
indicating	NULL
the	NULL
relative	NULL
mobilities	NULL
of	NULL
13969	NULL
human	NULL
and	NULL
rat	NULL
SIF	NULL
complexes	NULL
,	NULL
respectively	NULL
(	NULL
16	NULL
,	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
cell	NULL
extracts	NULL
(	NULL
30	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
6	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon	NULL
P	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
,	NULL
and	NULL
reacted	NULL
with	NULL
anti-STAT5	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
complex	NULL
was	NULL
visualized	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
reaction	NULL
(	NULL
Am-ersham	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
plasma	NULL
proteins	NULL
secreted	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
was	NULL
quantitated	NULL
by	NULL
immuncelectrophoresis	NULL
using	NULL
monospecific	NULL
antibodies	NULL
to	NULL
human	NULL
plasma	NULL
proteins	NULL
(	NULL
Dako	NULL
Corp.	NULL
)	NULL
.	NULL

Total	NULL
cell	NULL
RNA	NULL
were	NULL
extracted	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
formaldehyde-containing	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
Nytran	NULL
Plus	NULL
membrane	NULL
(	NULL
Scheicher	NULL
&	NULL
Schuell	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
hybridization	NULL
with	NULL
``	NULL
°P-labeled	NULL
IL-10R	NULL
eDNA	NULL
(	NULL
4	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
IL-10	NULL
Activates	NULL
STAT	NULL
Proteins	NULL
in	NULL
Leukocytes-The	NULL
primary	NULL
structure	NULL
of	NULL
the	NULL
IL-10R	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
box	NULL
3	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
at	NULL
positions	NULL
446-449	NULL
(	NULL
YXRQ	NULL
)	NULL
and	NULL
496-499	NULL
(	NULL
YXKQ	NULL
)	NULL
in	NULL
the	NULL
human	NULL
receptor	NULL
(	NULL
4	NULL
)	NULL
and	NULL
at	NULL
positions	NULL
427-430	NULL
(	NULL
YXKQ	NULL
)	NULL
and	NULL
477-480	NULL
(	NULL
YXKQ	NULL
)	NULL
in	NULL
the	NULL
mouse	NULL
receptor	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Such	NULL
box	NULL
3	NULL
motifs	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
gp130	NULL
and	NULL
found	NULL
necessary	NULL
for	NULL
activating	NULL
STAT1	NULL
and	NULL
STAT3	NULL
and	NULL
for	NULL
inducing	NULL
transcription	NULL
via	NULL
IL-6RE	NULL
(	NULL
23	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
IL-10R	NULL
exerted	NULL
a	NULL
signaling	NULL
reaction	NULL
with	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
IL-6R	NULL
.	NULL

As	NULL
the	NULL
first	NULL
step	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
STAT	NULL
activation	NULL
patterns	NULL
in	NULL
cells	NULL
constitutively	NULL
expressing	NULL
both	NULL
receptors	NULL
(	NULL
37	NULL
)	NULL
and	NULL
used	NULL
lymphocytes	NULL
isolated	NULL
from	NULL
a	NULL
B-cell	NULL
CLL	NULL
patient	NULL
.	NULL

Treatment	NULL
with	NULL
various	NULL
cytokines	NULL
revealed	NULL
the	NULL
receptor-specific	NULL
recruitment	NULL
of	NULL
latent	NULL
DNA	NULL
binding	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
Second	NULL
Preparation	NULL
)	NULL
.	NULL

The	NULL
extracts	NULL
from	NULL
IL-10-	NULL
and	NULL
IL-6-treated	NULL
cells	NULL
produced	NULL
complexes	NULL
that	NULL
comi-grated	NULL
with	NULL
SIF-A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
which	NULL
,	NULL
based	NULL
on	NULL
the	NULL
previous	NULL
analyses	NULL
(	NULL
33	NULL
,	NULL
38	NULL
)	NULL
,	NULL
consisted	NULL
of	NULL
SIE	NULL
bound	NULL
to	NULL
STAT3	NULL
homodimer	NULL
,	NULL
STAT3	NULL
and	NULL
STAT1	NULL
heterodimer	NULL
,	NULL
and	NULL
STAT1	NULL
homodimer	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
to	NULL
the	NULL
SIF	NULL
patterns	NULL
was	NULL
also	NULL
detected	NULL
by	NULL
antibody	NULL
supershift	NULL
assay	NULL
(	NULL
Figs	NULL
.	NULL

1C	NULL
and	NULL
2B	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
responded	NULL
to	NULL
IL-4	NULL
and	NULL
IFNy	NULL
by	NULL
activating	NULL
appropriately	NULL
STAT6	NULL
and	NULL
STAT1	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
factors	NULL
yielded	NULL
the	NULL
characteristic	NULL
EMSA	NULL
patterns	NULL
with	NULL
SIE	NULL
and	NULL
TB-2	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

IL-2	NULL
and	NULL
IL-15	NULL
were	NULL
ineffective	NULL
;	NULL
thus	NULL
,	NULL
a	NULL
receptor	NULL
activation	NULL
of	NULL
STATS	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
STAT	NULL
activation	NULL
pattern	NULL
in	NULL
the	NULL
freshly	NULL
isolated	NULL
lymphocyte	NULL
preparation	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
in	NULL
cells	NULL
collected	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
one	NULL
year	NULL
earlier	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
First	NULL
Preparation	NULL
)	NULL
.	NULL

Differences	NULL
appeared	NULL
to	NULL
be	NULL
quantitative	NULL
and	NULL
included	NULL
a	NULL
more	NULL
effective	NULL
activation	NULL
of	NULL
the	NULL
SIF-C	NULL
complex	NULL
by	NULL
IL-6	NULL
and	NULL
a	NULL
lower	NULL
IL-4	NULL
response	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
IL-10	NULL
and	NULL
IL-6	NULL
to	NULL
activate	NULL
SIE-binding	NULL
factors	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
CLL	NULL
cells	NULL
collected	NULL
from	NULL
different	NULL
patients	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
IL-10	NULL
was	NULL
highly	NULL
effective	NULL
,	NULL
whereas	NULL
IL-6	NULL
action	NULL
was	NULL
more	NULL
variable	NULL
.	NULL

By	NULL
antibody	NULL
supershift	NULL
assay	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
STAT3	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
STAT1	NULL
contributed	NULL
to	NULL
the	NULL
complex	NULL
SIF	NULL
pattern	NULL
as	NULL
noted	NULL
in	NULL
the	NULL
example	NULL
of	NULL
the	NULL
IL-10-	NULL
or	NULL
IL-6-treated	NULL
CLL	NULL
cells	NULL
from	NULL
patient	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
EMSA	NULL
patterns	NULL
obtained	NULL
with	NULL
extracts	NULL
from	NULL
CLL	NULL
cells	NULL
were	NULL
highly	NULL
similar	NULL
to	NULL
the	NULL
patterns	NULL
from	NULL
IL-6-treated	NULL
HepG2	NULL
cells	NULL
,	NULL
whose	NULL
STAT1	NULL
and	NULL
STAT3	NULL
compositions	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
were	NULL
in	NULL
agreement	NULL
with	NULL
published	NULL
data	NULL
(	NULL
33	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
minor	NULL
response	NULL
to	NULL
IL-6	NULL
of	NULL
some	NULL
of	NULL
the	NULL
CLL	NULL
cell	NULL
preparations	NULL
(	NULL
eg	NULL
.	NULL

Patient	NULL
6	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
may	NULL
in	NULL
part	NULL
be	NULL
due	NULL
to	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
effective	NULL
IL-6R	NULL
subunits	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
despite	NULL
the	NULL
rather	NULL
drastic	NULL
differences	NULL
in	NULL
intensities	NULL
,	NULL
the	NULL
SIF	NULL
patterns	NULL
produced	NULL
by	NULL
IL-10	NULL
and	NULL
IL-6	NULL
in	NULL
the	NULL
individual	NULL
cell	NULL
preparations	NULL
showed	NULL
comparable	NULL
qualitative	NULL
compositions	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
whether	NULL
the	NULL
pattern	NULL
of	NULL
STAT	NULL
activation	NULL
by	NULL
the	NULL
IL-10R	NULL
in	NULL
CCL	NULL
cells	NULL
was	NULL
representative	NULL
for	NULL
other	NULL
IL-10R-bear-ing	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
freshly	NULL
isolated	NULL
resting	NULL
T-cells	NULL
,	NULL
and	NULL
cells	NULL
from	NULL
the	NULL
established	NULL
NK-92	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
SIF	NULL
pattern	NULL
,	NULL
IL-10	NULL
prominently	NULL
activated	NULL
STAT3	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
STAT1	NULL
,	NULL
which	NULL
could	NULL
be	NULL
verified	NULL
by	NULL
antibody	NULL
supershift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

IL-6	NULL
was	NULL
only	NULL
effective	NULL
in	NULL
T-cells	NULL
and	NULL
elicited	NULL
a	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
13970	NULL
A	NULL
Second	NULL
Preparation	NULL
First	NULL
Preparation	NULL
|Std	NULL
~	NULL
SIF-A	NULL
SIE	NULL
-	NULL
sIPB	NULL
--	NULL
SIF-C	NULL
#	NULL
3	NULL
TB-2	NULL
tnd	NULL
--	NULL
SIF-A	NULL
-	NULL
SIFB	NULL
-	NULL
SIEC	NULL
6	NULL
uR	NULL
O	NULL
uPLP	NULL
®	NULL
,	NULL
»	NULL
8	NULL
o	NULL
@	NULL
Z	NULL
®	NULL
-	NULL
&	NULL
Y	NULL
wQQQ	NULL
‘	NULL
lﬁww	NULL
¥	NULL
q	NULL
``	NULL
y	NULL
``	NULL
C/y	NULL
Treatment	NULL
B	NULL
Patient1	NULL
|Patien1	NULL
zlPatient	NULL
3|	NULL
Patient4|	NULL
Patient	NULL
5	NULL
|	NULL
Patient	NULL
6	NULL
iStd	NULL
-	NULL
<	NULL
SIF-A	NULL
-	NULL
SIF-B	NULL
-*	NULL
SIF-C	NULL
J.	NULL
éo	NULL
_	NULL
>	NULL
W/é	NULL
&	NULL
%	NULL
o	NULL
50V	NULL
Q0	NULL
°	NULL
y	NULL
'	NULL
C	NULL
>	NULL
\/§	NULL
®	NULL
VJ	NULL
!	NULL

Treatment	NULL
o	NULL
CLL	NULL
Cells	NULL
___	NULL
|..	NULL
HepG2	NULL
Cells	NULL
_	NULL
IL-10	NULL
IL-6	NULL
IL-6	NULL
wn	NULL
#	NULL
a	NULL
-*	NULL
Anti-STATS	NULL
[	NULL
supershifted	NULL
#	NULL
Complex	NULL
-	NULL
Anti-STAT1	NULL
e	NULL
a	NULL
.	NULL

&	NULL
u	NULL
supershifted	NULL
SIF-A~	NULL
4	NULL
ls	NULL
Complex	NULL
SIF	NULL
-B	NULL
»	NULL
g	NULL
sIF-C	NULL
»	NULL
-|	NULL
we	NULL
|-SIF-B	NULL
t	NULL
dv	NULL
cag	NULL
+-sI2-C	NULL
-	NULL
|	NULL
+	NULL
[	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
|	NULL
+	NULL
|	NULL
-	NULL
|	NULL
-	NULL
Ab	NULL
=-	NULL
|T	NULL
-	NULL
-	NULL
-	NULL
|	NULL
-	NULL
-	NULL
_|Anti-STAT3	NULL
1	NULL
[	NULL
L-	NULL
[	NULL
+-	NULL
]	NULL
-	NULL
[	NULL
-	NULL
[	NULL
+	NULL
-	NULL
[	NULL
_-	NULL
[	NULL
-	NULL
|	NULL
4+	NULL
|Ant-sTAm	NULL
D	NULL
CLL	NULL
Std	NULL
SIFA+-	NULL
[	NULL
dy	NULL
|	NULL
‘	NULL
m	NULL
ﬂ	NULL
<	NULL
SIF-A	NULL
SIF-B+	NULL
%	NULL
-	NULL
SIF-B	NULL
SIF-C*	NULL
%	NULL
-=	NULL
SIF-C	NULL
10	NULL
6	NULL
10	NULL
6	NULL
10	NULL
6	NULL
10	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
STATs	NULL
in	NULL
CLL	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
CLL	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
one	NULL
patient	NULL
(	NULL
First	NULL
Preparation	NULL
)	NULL
and	NULL
stored	NULL
frozen	NULL
.	NULL

One	NULL
year	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
(	NULL
Second	NULL
Preparation	NULL
)	NULL
and	NULL
used	NULL
immediately	NULL
.	NULL

The	NULL
cells	NULL
from	NULL
the	NULL
first	NULL
preparation	NULL
were	NULL
thawed	NULL
and	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
medium	NULL
prior	NULL
to	NULL
treatment	NULL
.	NULL

Aliquots	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
the	NULL
cytokines	NULL
listed	NULL
at	NULL
the	NULL
boffom	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
cell	NULL
extracts	NULL
were	NULL
analyzed	NULL
in	NULL
duplicates	NULL
by	NULL
EMSA	NULL
for	NULL
SIE	NULL
or	NULL
TB-2	NULL
binding	NULL
activities	NULL
.	NULL

Extracts	NULL
of	NULL
IL-6-treated	NULL
HepG2	NULL
cells	NULL
served	NULL
as	NULL
standard	NULL
(	NULL
Std	NULL
)	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
SIF	NULL
complexes	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
CLL	NULL
cells	NULL
isolated	NULL
from	NULL
6	NULL
patients	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
IL-10	NULL
or	NULL
IL-6	NULL
and	NULL
analyzed	NULL
for	NULL
SIE	NULL
binding	NULL
activity	NULL
as	NULL
in	NULL
A	NULL
.	NULL

The	NULL
band	NULL
at	NULL
the	NULL
lower	NULL
part	NULL
,	NULL
representing	NULL
nonspecific	NULL
binding	NULL
activity	NULL
,	NULL
is	NULL
shown	NULL
to	NULL
illustrate	NULL
comparable	NULL
binding	NULL
reactions	NULL
.	NULL

C	NULL
,	NULL
equal	NULL
aliquots	NULL
of	NULL
the	NULL
CLL-cell	NULL
extract	NULL
from	NULL
the	NULL
patient	NULL
in	NULL
A	NULL
were	NULL
subjected	NULL
to	NULL
anti-STAT1	NULL
and	NULL
anti-STAT3	NULL
supershift	NULL
assay	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
extract	NULL
of	NULL
HepG2	NULL
cells	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
IL-6	NULL
was	NULL
similarly	NULL
analyzed	NULL
.	NULL

The	NULL
EMSA	NULL
patterns	NULL
,	NULL
after	NULL
5	NULL
h	NULL
(	NULL
Cll	NULL
IL-10	NULL
and	NULL
HepG2	NULL
IL-6	NULL
)	NULL
and	NULL
after	NULL
14	NULL
h	NULL
(	NULL
CLL	NULL
IL-6	NULL
)	NULL
exposure	NULL
,	NULL
are	NULL
shown	NULL
.	NULL

D	NULL
,	NULL
SIF	NULL
complexes	NULL
induced	NULL
by	NULL
IL-10	NULL
and	NULL
IL-6	NULL
in	NULL
individual	NULL
preparations	NULL
of	NULL
CLL	NULL
cells	NULL
from	NULL
patient	NULL
2-5	NULL
in	NULL
B	NULL
were	NULL
compared	NULL
by	NULL
combining	NULL
autoradiographic	NULL
images	NULL
of	NULL
different	NULL
lengths	NULL
of	NULL
exposures	NULL
to	NULL
yield	NULL
EMSA	NULL
patterns	NULL
with	NULL
similar	NULL
intensities	NULL
.	NULL

IL-10	NULL
Receptor	NULL
Signaling	NULL
A	NULL
T-Cells	NULL
NK-92	NULL
Cells	NULL
.	NULL

-SIFA	NULL
SIE	NULL
.l	NULL
tip	NULL
-	NULL
SIF-C	NULL
#	NULL
15	NULL
08	NULL
&	NULL
&	NULL
5	NULL
®	NULL
5	NULL
.8	NULL
gs	NULL
NVNQQ	NULL
``	NULL
s*	NULL
»	NULL
&	NULL
T-Cells	NULL
NK-92	NULL
)	NULL
CLL	NULL
iL-s	NULL
|	NULL
iL-40	NULL
|	NULL
IL.40	NULL
|	NULL
ik-10	NULL
®	NULL
Supershifted	NULL
Complex	NULL
.	NULL

-SIF-A	NULL
-	NULL
SIF-B	NULL
+SIF-C	NULL
+	NULL
[	NULL
-=	NULL
4+	NULL
T=	NULL
4	NULL
{	NULL
-	NULL
+	NULL
Ant-STATs	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Cell	NULL
type-specific	NULL
differences	NULL
in	NULL
patterns	NULL
of	NULL
activated	NULL
STATs	NULL
.	NULL

A	NULL
,	NULL
preparations	NULL
of	NULL
freshly	NULL
isolated	NULL
resting	NULL
T-cells	NULL
and	NULL
cells	NULL
from	NULL
the	NULL
established	NULL
NK-92	NULL
line	NULL
were	NULL
treated	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
each	NULL
)	NULL
with	NULL
the	NULL
factors	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
for	NULL
SIE	NULL
and	NULL
TB-2	NULL
binding	NULL
activity	NULL
.	NULL

B	NULL
,	NULL
extracts	NULL
from	NULL
the	NULL
indicated	NULL
cells	NULL
,	NULL
which	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
either	NULL
IL-6	NULL
or	NULL
IL-10	NULL
(	NULL
CLL	NULL
cells	NULL
derived	NULL
from	NULL
patient	NULL
2	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
were	NULL
reacted	NULL
with	NULL
or	NULL
without	NULL
anti-STAT3	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
for	NULL
SIE	NULL
binding	NULL
activity	NULL
.	NULL

strong	NULL
activation	NULL
of	NULL
STAT1	NULL
and	NULL
-3	NULL
.	NULL

The	NULL
IL-2	NULL
or	NULL
IL-15	NULL
response	NULL
in	NULL
T-cells	NULL
and	NULL
NK-92	NULL
cells	NULL
demonstrated	NULL
that	NULL
these	NULL
cells	NULL
,	NULL
unlike	NULL
CLL	NULL
cells	NULL
,	NULL
express	NULL
and	NULL
activate	NULL
STATS	NULL
that	NULL
produced	NULL
a	NULL
prominent	NULL
complex	NULL
with	NULL
TB-2	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
relatively	NULL
minor	NULL
TB-2-bound	NULL
complex	NULL
was	NULL
also	NULL
noted	NULL
in	NULL
IL-10-treated	NULL
T-cells	NULL
,	NULL
this	NULL
complex	NULL
was	NULL
not	NULL
recognized	NULL
by	NULL
anti-STATS5	NULL
in	NULL
supershift	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
may	NULL
represent	NULL
complexes	NULL
including	NULL
STAT1	NULL
and/or	NULL
STAT3	NULL
(	NULL
22	NULL
)	NULL
.	NULL
``	NULL

Specificity	NULL
of	NULL
STAT	NULL
Activation	NULL
by	NULL
the	NULL
Human	NULL
IL-10R-Since	NULL
each	NULL
of	NULL
the	NULL
lymphocyte	NULL
types	NULL
analyzed	NULL
in	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
contained	NULL
a	NULL
characteristic	NULL
and	NULL
complex	NULL
mixture	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
a	NULL
precise	NULL
assessment	NULL
of	NULL
the	NULL
IL-10R	NULL
's	NULL
capability	NULL
to	NULL
activate	NULL
individual	NULL
STAT	NULL
proteins	NULL
and	NULL
to	NULL
compare	NULL
its	NULL
action	NULL
with	NULL
that	NULL
of	NULL
the	NULL
IL-6R	NULL
was	NULL
difficult	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
defined	NULL
the	NULL
signaling	NULL
potential	NULL
of	NULL
the	NULL
IL-10R	NULL
by	NULL
reconstitution	NULL
in	NULL
the	NULL
IL-10R-deficient	NULL
COS-1	NULL
cells	NULL
using	NULL
overexpressed	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

To	NULL
grade	NULL
the	NULL
specificity	NULL
and	NULL
efficacy	NULL
of	NULL
the	NULL
signaling	NULL
,	NULL
we	NULL
tested	NULL
in	NULL
parallel	NULL
transfected	NULL
G-CSFR	NULL
.	NULL

The	NULL
G-CSFR	NULL
was	NULL
selected	NULL
because	NULL
like	NULL
the	NULL
IL-10R	NULL
,	NULL
it	NULL
is	NULL
a	NULL
homo-oligomeric	NULL
receptor	NULL
(	NULL
39	NULL
)	NULL
,	NULL
contains	NULL
one	NULL
box	NULL
3	NULL
motif	NULL
,	NULL
and	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
with	NULL
equal	NULL
efficiency	NULL
STAT1	NULL
,	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
patterns	NULL
with	NULL
SIE	NULL
)	NULL
,	NULL
and	NULL
STAT5B	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
patterns	NULL
with	NULL
TB-2	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
IL-10R	NULL
activated	NULL
STAT1	NULL
and	NULL
STAT3	NULL
.	NULL

By	NULL
comparing	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
SIF	NULL
complexes	NULL
,	NULL
the	NULL
IL-10R	NULL
,	NULL
unlike	NULL
the	NULL
G-CSFR	NULL
,	NULL
appeared	NULL
to	NULL
have	NULL
a	NULL
higher	NULL
preference	NULL
for	NULL
STAT3	NULL
than	NULL
STATLI	NULL
.	NULL

The	NULL
STAT3	NULL
preference	NULL
was	NULL
also	NULL
noted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
overexpressed	NULL
STATL	NULL
.	NULL

One	NULL
half	NULL
of	NULL
the	NULL
radioactivity	NULL
was	NULL
confined	NULL
to	NULL
a	NULL
het-erodimeric	NULL
complex	NULL
that	NULL
included	NULL
transfected	NULL
STAT1	NULL
and	NULL
*	NULL
J.	NULL
Ripperger	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
IL-10	NULL
Receptor	NULL
Signaling	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

STAT	NULL
specificity	NULL
of	NULL
IL-10R	NULL
A	NULL
action	NULL
.	NULL

A	NULL
,	NULL
COS-1	NULL
cells	NULL
were	NULL
transfected	NULL
183971	NULL
with	NULL
G-CSFR	NULL
or	NULL
IL-10R	NULL
together	NULL
with	NULL
ei-	NULL
G-CSFR	NULL
IL-10R	NULL
[	NULL
a-csrn	NULL
|	NULL
__|	NULL
ther	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
control	NULL
)	NULL
or	NULL
Std	NULL
|	NULL
stam	NULL
__|	NULL
STAT3	NULL
Contre	NULL
!	NULL

|	NULL
STATi|	NULL
Stats	NULL
|	NULL
|	NULL
STATSB	NULL
|STATSB	NULL
]	NULL
STATe	NULL
|	NULL
STATI1a	NULL
,	NULL
STAT3	NULL
,	NULL
STAT5B	NULL
,	NULL
or	NULL
STATé6	NULL
.	NULL

SIE	NULL
P	NULL
TB-2	NULL
Transfected	NULL
cultures	NULL
were	NULL
divided	NULL
and	NULL
treated	NULL
as	NULL
noted	NULL
at	NULL
the	NULL
boffom	NULL
.	NULL

Equal	NULL
SIP	NULL
-A	NULL
=	NULL
.	NULL

amounts	NULL
of	NULL
cell	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
siFB	NULL
«	NULL
-	NULL
‘	NULL
.	NULL

EMSA	NULL
for	NULL
SIE	NULL
(	NULL
Zeft	NULL
panel	NULL
,	NULL
exposed	NULL
for	NULL
6	NULL
h	NULL
)	NULL
sir.c-~	NULL
.	NULL

.	NULL

or	NULL
TB-2	NULL
binding	NULL
activity	NULL
(	NULL
right	NULL
panel	NULL
,	NULL
ex-	NULL
‘	NULL
posed	NULL
for	NULL
16	NULL
h	NULL
)	NULL
.	NULL

The	NULL
nonspecific	NULL
binding	NULL
complex	NULL
in	NULL
the	NULL
lower	NULL
half	NULL
in	NULL
the	NULL
TB-2	NULL
pat	NULL
tern	NULL
illustrates	NULL
that	NULL
comparable	NULL
reaction	NULL
me	NULL
|	NULL
-	NULL
oa	NULL
I-	NULL
oal	NULL
-	NULL
aol	NULL
-	NULL
aol	NULL
-	NULL
10	NULL
-	NULL
e	NULL
|-	NULL
01	NULL
-	NULL
10	NULL
conditions	NULL
were	NULL
used	NULL
.	NULL

The	NULL
standard	NULL
(	NULL
Std	NULL
)	NULL
on	NULL
the	NULL
left	NULL
represents	NULL
extract	NULL
of	NULL
IL-6-treated	NULL
H-85	NULL
cells	NULL
,	NULL
illustrating	NULL
the	NULL
rela-	NULL
B	NULL
tive	NULL
positions	NULL
of	NULL
rat	NULL
SIF-A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C.	NULL
B	NULL
,	NULL
aliquots	NULL
of	NULL
extracts	NULL
selected	NULL
from	NULL
A	NULL
were	NULL
separated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
for	NULL
STATS5	NULL
.	NULL

STAT5B	NULL
tyrosine	NULL
phos-phorylated	NULL
by	NULL
G-CSF	NULL
treatment	NULL
migrates	NULL
slower	NULL
(	NULL
STAT5*	NULL
)	NULL
and	NULL
reacts	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-10R	NULL
G-csFh	NULL
Contre	NULL
!	NULL

|	NULL
sTtATsEB	NULL
|_	NULL
stati	NULL
|	NULL
stAtsB	NULL
<	NULL
STATS®	NULL
<	NULL
»	NULL
am	NULL
iG	NULL
+sTats	NULL
-	NULL
ae	NULL
|-	NULL
ae	NULL
1	NULL
-	NULL
a	NULL
|	NULL
-	NULL
a	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Induction	NULL
of	NULL
transcription	NULL
by	NULL
IL-10R	NULL
.	NULL

HepG2	NULL
cells	NULL
were	NULL
transfected	NULL
wt	NULL
6	NULL
-	NULL
_	NULL
10	NULL
6	NULL
-	NULL
_	NULL
10	NULL
6	NULL
-	NULL
10	NULL
pHARE-CAT	NULL
pIL-6RE-CAT	NULL
WM8A	NULL
$	NULL
700y	NULL
pspl'ggjrozo	NULL
)	NULL
‘	NULL
pCRP	NULL
(	NULL
219	NULL
)	NULL
-CAT	NULL
[	NULL
1	NULL
|	NULL
»	NULL
|	NULL
ai	NULL
1	NULL
[	NULL
«	NULL
]	NULL
s	NULL
]	NULL
|	NULL
[	NULL
1	NULL
[	NULL
is	NULL
|	NULL
x	NULL
]	NULL
|	NULL
[	NULL
1	NULL
[	NULL
&	NULL
e	NULL
]	NULL
[	NULL
a	NULL
#	NULL
]	NULL
[	NULL
1	NULL
[	NULL
z	NULL
]	NULL
|	NULL
2	NULL
|	NULL
»	NULL
|	NULL
a	NULL
]	NULL
with	NULL
IL-10R	NULL
expression	NULL
vector	NULL
together	NULL
with	NULL
the	NULL
CAT	NULL
gene	NULL
reporter	NULL
constructs	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Subcultures	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
cytokines	NULL
listed	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

The	NULL
thin	NULL
layer	NULL
patterns	NULL
of	NULL
representative	NULL
CAT	NULL
activity	NULL
assays	NULL
are	NULL
repro-duced	NULL
.	NULL

The	NULL
numerical	NULL
values	NULL
for	NULL
relative	NULL
change	NULL
in	NULL
activity	NULL
are	NULL
marked	NULL
above	NULL
.	NULL

Data	NULL
not	NULL
shown	NULL
indicated	NULL
that	NULL
:	NULL
1	NULL
)	NULL
without	NULL
co-transfected	NULL
IL-10R	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
constructs	NULL
remained	NULL
unchanged	NULL
by	NULL
IL-10	NULL
treatment	NULL
,	NULL
and	NULL
2	NULL
)	NULL
IL-1	NULL
treatment	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
pCRP	NULL
(	NULL
219	NULL
)	NULL
-CAT	NULL
did	NULL
not	NULL
stimulate	NULL
CAT	NULL
expression	NULL
.	NULL

6	NULL
10+t	NULL
641	NULL
COS-1	NULL
STAT3	NULL
and	NULL
migrated	NULL
slower	NULL
than	NULL
the	NULL
rat	NULL
STAT1	NULL
ho-modimer	NULL
(	NULL
SIF-C	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
endogenous	NULL
COS-1	NULL
STAT3	NULL
by	NULL
transfected	NULL
IL-10R	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
major	NULL
band	NULL
in	NULL
the	NULL
lane	NULL
labeled	NULL
control	NULL
+	NULL
10	NULL
is	NULL
COS-1	NULL
SIF-A	NULL
)	NULL
was	NULL
particularly	NULL
notable	NULL
because	NULL
transfection	NULL
of	NULL
various	NULL
hematopoietin	NULL
receptors	NULL
,	NULL
including	NULL
the	NULL
G-CSFR	NULL
and	NULL
those	NULL
for	NULL
IL-6-type	NULL
cytokines	NULL
,	NULL
had	NULL
yielded	NULL
primarily	NULL
activation	NULL
of	NULL
COS-1	NULL
STAT1	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

No	NULL
detectable	NULL
effect	NULL
of	NULL
the	NULL
IL-10R	NULL
on	NULL
STAT5B	NULL
or	NULL
-6	NULL
was	NULL
evident	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
STATS5B	NULL
activation	NULL
appeared	NULL
to	NULL
distinguish	NULL
the	NULL
IL-10R	NULL
from	NULL
many	NULL
hematopoietin	NULL
receptors	NULL
including	NULL
the	NULL
G-CSFR	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
TB-2	NULL
panel	NULL
)	NULL
,	NULL
which	NULL
have	NULL
shown	NULL
the	NULL
potential	NULL
to	NULL
activate	NULL
STATS5	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

That	NULL
the	NULL
reconstituted	NULL
COS-1	NULL
cells	NULL
provided	NULL
abundant	NULL
amounts	NULL
of	NULL
STATS5	NULL
proteins	NULL
was	NULL
verified	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
signaling	NULL
functions	NULL
initiated	NULL
by	NULL
the	NULL
IL-10R	NULL
in	NULL
the	NULL
normal	NULL
cell	NULL
environment	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
could	NULL
be	NULL
accurately	NULL
reproduced	NULL
by	NULL
transfection	NULL
into	NULL
heterologous	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
the	NULL
IL-10R	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
activating	NULL
STAT5	NULL
,	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
box	NULL
3-containing	NULL
hematopoietin	NULL
receptors	NULL
,	NULL
but	NULL
clearly	NULL
differed	NULL
from	NULL
IFNw	NULL
@	NULL
/BR	NULL
or	NULL
IFNyR	NULL
,	NULL
even	NULL
though	NULL
,	NULL
like	NULL
the	NULL
IL-10R	NULL
,	NULL
the	NULL
latter	NULL
two	NULL
receptors	NULL
utilized	NULL
JAK1	NULL
and	NULL
TYK2	NULL
as	NULL
signal-communicating	NULL
kinases	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Signaling	NULL
by	NULL
the	NULL
IL-10R	NULL
may	NULL
involve	NULL
reactions	NULL
that	NULL
have	NULL
been	NULL
predicted	NULL
for	NULL
gp130	NULL
(	NULL
31	NULL
,	NULL
42	NULL
)	NULL
and	NULL
may	NULL
entail	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
tyrosine	NULL
residue	NULL
in	NULL
box	NULL
3	NULL
that	NULL
in	NULL
turn	NULL
serves	NULL
as	NULL
a	NULL
high	NULL
affinity	NULL
docking	NULL
site	NULL
for	NULL
STAT3	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
,	NULL
for	NULL
STAT1	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
STAT	NULL
function	NULL
is	NULL
conceivably	NULL
due	NULL
to	NULL
the	NULL
action	NULL
of	NULL
IL-10R-associated	NULL
JAK1	NULL
and/or	NULL
TYK2	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

IL-10R	NULL
Induces	NULL
Transcription	NULL
of	NULL
IL-6-responsive	NULL
Genes-To	NULL
assess	NULL
whether	NULL
the	NULL
IL-10R	NULL
executed	NULL
a	NULL
gp130-like	NULL
effect	NULL
not	NULL
only	NULL
on	NULL
STAT	NULL
activation	NULL
but	NULL
also	NULL
on	NULL
gene	NULL
transcription	NULL
that	NULL
may	NULL
or	NULL
may	NULL
not	NULL
be	NULL
caused	NULL
by	NULL
STAT	NULL
's	NULL
,	NULL
we	NULL
needed	NULL
a	NULL
suitable	NULL
experimental	NULL
assay	NULL
system	NULL
.	NULL

Since	NULL
we	NULL
had	NULL
no	NULL
adequate	NULL
molecular	NULL
tools	NULL
available	NULL
to	NULL
study	NULL
gene	NULL
induction	NULL
by	NULL
IL-6	NULL
or	NULL
IL-10	NULL
in	NULL
leukocytes	NULL
,	NULL
we	NULL
resorted	NULL
to	NULL
the	NULL
application	NULL
of	NULL
hepatoma	NULL
cells	NULL
as	NULL
surrogate	NULL
system	NULL
.	NULL

Hepatoma	NULL
cells	NULL
were	NULL
attractive	NULL
because	NULL
the	NULL
IL-6R-mediated	NULL
gene	NULL
induction	NULL
had	NULL
been	NULL
well	NULL
characterized	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
the	NULL
signaling	NULL
process	NULL
could	NULL
experimentally	NULL
be	NULL
manipulated	NULL
.	NULL

We	NULL
transfected	NULL
the	NULL
IL-10R	NULL
together	NULL
with	NULL
characteristic	NULL
IL-6-responsive	NULL
CAT	NULL
gene	NULL
constructs	NULL
,	NULL
pHRRE-CAT	NULL
and	NULL
pIL-6RE-CAT	NULL
,	NULL
into	NULL
HepG2	NULL
cells	NULL
.	NULL

We	NULL
had	NULL
verified	NULL
that	NULL
HepG2	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
endogenous	NULL
IL-10R	NULL
mRNA	NULL
nor	NULL
respond	NULL
to	NULL
IL-10	NULL
treatment	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
)	NULL
.	NULL

IL-10	NULL
treatment	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
stimulated	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
CAT	NULL
gene	NULL
constructs	NULL
to	NULL
a	NULL
level	NULL
achieved	NULL
by	NULL
IL-6	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
ectopically	NULL
expressed	NULL
IL-10R	NULL
was	NULL
able	NULL
to	NULL
engage	NULL
the	NULL
cellular	NULL
signaling	NULL
mechanisms	NULL
like	NULL
the	NULL
endogenous	NULL
IL-6R	NULL
.	NULL

The	NULL
CAT	NULL
constructs	NULL
represented	NULL
artificial	NULL
and	NULL
optimized	NULL
response	NULL
systems	NULL
whose	NULL
regulation	NULL
might	NULL
substantially	NULL
differ	NULL
from	NULL
that	NULL
of	NULL
natural	NULL
gene	NULL
promoters	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
CAT	NULL
reporter	NULL
gene	NULL
constructs	NULL
that	NULL
contained	NULL
promoter	NULL
and	NULL
5	NULL
flanking	NULL
regions	NULL
of	NULL
representative	NULL
APP	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
of	NULL
the	NULL
type	NULL
2	NULL
rat	NULL
APP	NULL
genes	NULL
,	NULL
«	NULL
,	NULL
-MG	NULL
and	NULL
SPI-3	NULL
,	NULL
both	NULL
containing	NULL
an	NULL
APRE-related	NULL
sequence	NULL
,	NULL
responded	NULL
equally	NULL
to	NULL
the	NULL
IL-10R	NULL
and	NULL
IL-6R	NULL
signal	NULL
.	NULL

A	NULL
hallmark	NULL
of	NULL
the	NULL
IL-6	NULL
action	NULL
is	NULL
not	NULL
only	NULL
the	NULL
specific	NULL
induction	NULL
of	NULL
type	NULL
2	NULL
APP	NULL
genes	NULL
but	NULL
also	NULL
the	NULL
synergism	NULL
with	NULL
IL-1	NULL
on	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
13972	NULL
the	NULL
expression	NULL
of	NULL
type	NULL
1	NULL
APP	NULL
genes	NULL
such	NULL
as	NULL
human	NULL
CRP	NULL
(	NULL
26	NULL
)	NULL
.	NULL

A	NULL
219-bp	NULL
CRP	NULL
promoter	NULL
region	NULL
containing	NULL
the	NULL
elements	NULL
for	NULL
both	NULL
STAT3	NULL
and	NULL
C/EBP	NULL
transactivation	NULL
(	NULL
26	NULL
)	NULL
reproduced	NULL
this	NULL
synergism	NULL
in	NULL
transfected	NULL
HepG2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

With	NULL
transfected	NULL
IL-10R	NULL
,	NULL
the	NULL
gene	NULL
construct	NULL
was	NULL
induced	NULL
by	NULL
IL-10	NULL
alone	NULL
and	NULL
further	NULL
enhanced	NULL
by	NULL
IL-1	NULL
.	NULL

Of	NULL
note	NULL
was	NULL
that	NULL
the	NULL
IL-10	NULL
induction	NULL
of	NULL
the	NULL
CRP-CAT	NULL
construct	NULL
exceeded	NULL
the	NULL
IL-6	NULL
effect	NULL
by	NULL
severalfold	NULL
.	NULL

Gene	NULL
Induction	NULL
by	NULL
IL-10	NULL
Is	NULL
Unaffected	NULL
by	NULL
Overexpressed	NULL
STATs-Activation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
STAT	NULL
proteins	NULL
by	NULL
cytokines	NULL
has	NULL
often	NULL
be	NULL
considered	NULL
to	NULL
be	NULL
causal	NULL
to	NULL
induction	NULL
of	NULL
transcription	NULL
of	NULL
genes	NULL
containing	NULL
STAT	NULL
binding	NULL
motifs	NULL
in	NULL
their	NULL
promoter	NULL
regions	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
preference	NULL
of	NULL
hematopoietin	NULL
receptors	NULL
for	NULL
certain	NULL
STAT	NULL
proteins	NULL
has	NULL
been	NULL
employed	NULL
for	NULL
defining	NULL
the	NULL
gene	NULL
regulatory	NULL
role	NULL
of	NULL
the	NULL
individual	NULL
STAT	NULL
's	NULL
(	NULL
41	NULL
)	NULL
.	NULL

One	NULL
approach	NULL
is	NULL
to	NULL
enhance	NULL
the	NULL
stimulatory	NULL
effect	NULL
on	NULL
transcription	NULL
by	NULL
ectopic	NULL
overexpression	NULL
of	NULL
STAT	NULL
proteins	NULL
.	NULL

By	NULL
testing	NULL
combinations	NULL
of	NULL
hematopoietin	NULL
receptors	NULL
and	NULL
STAT	NULL
proteins	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
identified	NULL
that	NULL
the	NULL
regulation	NULL
via	NULL
IL-6RE	NULL
was	NULL
sensitive	NULL
to	NULL
STAT3	NULL
but	NULL
not	NULL
to	NULL
STAT5B	NULL
,	NULL
and	NULL
the	NULL
regulation	NULL
via	NULL
HRRE	NULL
was	NULL
sensitive	NULL
to	NULL
STATS5	NULL
but	NULL
not	NULL
to	NULL
STAT3	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
preference	NULL
of	NULL
IL-10R	NULL
for	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
suggested	NULL
that	NULL
IL-10R	NULL
signaling	NULL
to	NULL
the	NULL
IL-6RE-CAT	NULL
gene	NULL
might	NULL
potentially	NULL
be	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
higher	NULL
amounts	NULL
of	NULL
STAT3	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
determined	NULL
gene	NULL
regulation	NULL
by	NULL
IL-10R	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
overexpressed	NULL
STAT3	NULL
.	NULL

Overexpressed	NULL
STAT5B	NULL
served	NULL
as	NULL
a	NULL
control	NULL
because	NULL
it	NULL
was	NULL
not	NULL
expected	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
IL-10R	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
receptor	NULL
action	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
overexpressed	NULL
STAT	NULL
's	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
verified	NULL
by	NULL
comparing	NULL
the	NULL
responses	NULL
mediated	NULL
by	NULL
the	NULL
IL-10R	NULL
with	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
IL-6R	NULL
and	NULL
co-transfected	NULL
IL-3R	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
both	NULL
HRRE-CAT	NULL
and	NULL
IL-6RE-CAT	NULL
by	NULL
IL-10	NULL
,	NULL
like	NULL
that	NULL
by	NULL
IL-6	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
already	NULL
maximal	NULL
through	NULL
the	NULL
endogenous	NULL
signaling	NULL
mechanisms	NULL
of	NULL
HepG2	NULL
cells	NULL
.	NULL

Co-transfected	NULL
STAT3	NULL
or	NULL
STAT5B	NULL
proved	NULL
to	NULL
be	NULL
ineffective	NULL
in	NULL
significantly	NULL
enhancing	NULL
the	NULL
IL-10	NULL
or	NULL
IL-6	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
STAT	NULL
proteins	NULL
provided	NULL
by	NULL
HepG2	NULL
cells	NULL
did	NULL
not	NULL
limit	NULL
signaling	NULL
by	NULL
either	NULL
IL-10R	NULL
or	NULL
IL-6R	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
STAT	NULL
proteins	NULL
were	NULL
insufficient	NULL
for	NULL
full	NULL
signaling	NULL
by	NULL
the	NULL
box	NULL
3-deficient	NULL
IL-3R	NULL
.	NULL

We	NULL
achieved	NULL
,	NULL
however	NULL
,	NULL
the	NULL
expected	NULL
regulatory	NULL
action	NULL
by	NULL
the	NULL
IL-3R	NULL
through	NULL
STAT3	NULL
on	NULL
IL-6RE	NULL
and	NULL
through	NULL
STAT5B	NULL
on	NULL
HRRE	NULL
by	NULL
over-expression	NULL
.	NULL

This	NULL
result	NULL
also	NULL
documented	NULL
that	NULL
the	NULL
STAT	NULL
expression	NULL
vectors	NULL
used	NULL
for	NULL
our	NULL
analysis	NULL
yielded	NULL
an	NULL
enhanced	NULL
level	NULL
of	NULL
functional	NULL
STAT	NULL
proteins	NULL
in	NULL
the	NULL
transfected	NULL
HepG2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
oligomerized	NULL
STAT	NULL
binding	NULL
sites	NULL
in	NULL
reporter	NULL
gene	NULL
constructs	NULL
often	NULL
exaggerates	NULL
the	NULL
specific	NULL
STAT-induced	NULL
transcriptional	NULL
induction	NULL
by	NULL
cytokine	NULL
receptor	NULL
signals	NULL
(	NULL
15	NULL
,	NULL
25	NULL
,	NULL
43	NULL
)	NULL
.	NULL

While	NULL
the	NULL
observed	NULL
induction	NULL
proves	NULL
the	NULL
signaling	NULL
capability	NULL
and	NULL
specificity	NULL
of	NULL
the	NULL
receptors	NULL
and	NULL
the	NULL
cellular	NULL
factors	NULL
,	NULL
it	NULL
does	NULL
not	NULL
necessarily	NULL
explain	NULL
the	NULL
mode	NULL
of	NULL
regulation	NULL
that	NULL
might	NULL
occur	NULL
via	NULL
natural	NULL
promoters	NULL
containing	NULL
only	NULL
one	NULL
or	NULL
a	NULL
few	NULL
cognate	NULL
STAT	NULL
binding	NULL
sites	NULL
such	NULL
as	NULL
a	NULL
«	NULL
,	NULL
-MG	NULL
(	NULL
22	NULL
,	NULL
24	NULL
,	NULL
35	NULL
)	NULL
or	NULL
SPI-3	NULL
(	NULL
25	NULL
)	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
analyzed	NULL
the	NULL
influence	NULL
of	NULL
overexpressed	NULL
STAT	NULL
's	NULL
on	NULL
the	NULL
IL-10	NULL
regulation	NULL
of	NULL
these	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
IL-10R	NULL
elicited	NULL
a	NULL
signaling	NULL
that	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
IL-6R	NULL
and	NULL
again	NULL
was	NULL
not	NULL
appreciably	NULL
influenced	NULL
by	NULL
overexpressed	NULL
STAT3	NULL
or	NULL
STAT5B	NULL
.	NULL

This	NULL
receptor	NULL
specificity	NULL
was	NULL
highlighted	NULL
by	NULL
the	NULL
comparison	NULL
with	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
IL-3R	NULL
.	NULL

The	NULL
signaling	NULL
of	NULL
the	NULL
IL-3R	NULL
to	NULL
the	NULL
APRE-containing	NULL
a	NULL
,	NULL
-MG	NULL
was	NULL
more	NULL
effective	NULL
than	NULL
IL-10R	NULL
or	NULL
IL-6R	NULL
,	NULL
whereas	NULL
the	NULL
signaling	NULL
to	NULL
the	NULL
SPI-3	NULL
promoter	NULL
required	NULL
enhanced	NULL
expression	NULL
of	NULL
either	NULL
STAT3	NULL
or	NULL
STAT5B	NULL
(	NULL
44	NULL
)	NULL
.	NULL

IL-10R	NULL
,	NULL
like	NULL
many	NULL
hematopoietin	NULL
receptors	NULL
and	NULL
IFNyR	NULL
,	NULL
is	NULL
IL-10	NULL
Receptor	NULL
Signaling	NULL
A	NULL
BJ	NULL
Untreated	NULL
L410	NULL
-	NULL
(	NULL
ius	NULL
IL-3	NULL
120|-100-	NULL
9	NULL
&	NULL
I	NULL
HRRE-CGAT	NULL
P	NULL
&	NULL
T	NULL
Fold	NULL
Stimulation	NULL
Teaser	NULL
:	NULL
iv	NULL
ele	NULL
&	NULL
8	NULL
IL-8RE-CAT	NULL
ho	NULL
O	NULL
aree	NULL
a+	NULL
24	NULL
STAT3	NULL
,	NULL
MG	NULL
(	NULL
2700	NULL
)	NULL
-CAT	NULL
Fold	NULL
Stimulation	NULL
SPI-3	NULL
(	NULL
-148	NULL
)	NULL
-CAT	NULL
Contr	NULL
C	NULL
IL-10R	NULL
IL-6R	NULL
IL-3R	NULL
oo|-	NULL
l	NULL
B0	NULL
60	NULL
HRRE-CAT	NULL
i	NULL
:	NULL
20-	NULL
I	NULL
:	NULL
;	NULL
40	NULL
}	NULL
-	NULL
S	NULL
Fold	NULL
Stimulation	NULL
SPI-3	NULL
(	NULL
-148	NULL
)	NULL
-CAT	NULL
five	NULL
amare	NULL
20|-	NULL
44	NULL
a	NULL
22428	NULL
600	NULL
1	NULL
5	NULL
0	NULL
1	NULL
5	NULL
0	NULL
10	NULL
5	NULL
pSV-STATSBA40C	NULL
(	NULL
ug/ml	NULL
)	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
overexpressed	NULL
STAT	NULL
proteins	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
HepG2	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CAT	NULL
gene	NULL
reporter	NULL
constructs	NULL
listed	NULL
at	NULL
the	NULL
left	NULL
together	NULL
with	NULL
expression	NULL
vector	NULL
for	NULL
IL-10R	NULL
or	NULL
IL-3Ra	NULL
and	NULL
IL-3RB	NULL
as	NULL
indicated	NULL
.	NULL

Subcultures	NULL
of	NULL
each	NULL
series	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
untreated	NULL
)	NULL
of	NULL
treated	NULL
with	NULL
IL-10	NULL
or	NULL
IL-3	NULL
and	NULL
IL-6	NULL
.	NULL

The	NULL
relative	NULL
increase	NULL
in	NULL
CAT	NULL
expression	NULL
was	NULL
determined	NULL
.	NULL

Mean	NULL
values	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
3-6	NULL
separate	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

C	NULL
,	NULL
HepG2	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
CAT	NULL
gene	NULL
reporter	NULL
constructs	NULL
and	NULL
expression	NULL
vector	NULL
for	NULL
IL-10R	NULL
or	NULL
IL-3Ra	NULL
and	NULL
IL-3R	NULL
$	NULL
.	NULL

In	NULL
each	NULL
group	NULL
,	NULL
two	NULL
concentrations	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
for	NULL
STAT5BA40C	NULL
were	NULL
included	NULL
.	NULL

To	NULL
achieve	NULL
an	NULL
IL-3	NULL
stimulation	NULL
of	NULL
SPT-3	NULL
(	NULL
-148	NULL
)	NULL
-CAT	NULL
gene	NULL
,	NULL
the	NULL
transfection	NULL
of	NULL
those	NULL
cultures	NULL
contained	NULL
also	NULL
0.5	NULL
ug/ml	NULL
expression	NULL
vector	NULL
for	NULL
wild	NULL
type	NULL
STAT5B	NULL
.	NULL

The	NULL
relative	NULL
changes	NULL
in	NULL
CAT	NULL
activities	NULL
represent	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
two	NULL
to	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

O	NULL
If	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
IL-10	NULL
Receptor	NULL
Signaling	NULL
13973	NULL
n	NULL
a	NULL
&	NULL
IL-10R-A	NULL
a	NULL
«	NULL
$	NULL
99	NULL
s	NULL
$	NULL
3252	NULL
C	NULL
Mepas	NULL
&	NULL
§	NULL
0	NULL
&	NULL
L	NULL
.	NULL

HepG2	NULL
Cells	NULL
Q	NULL
‘	NULL
QQ	NULL
\\	NULL
;	NULL
\	NULL
CLL	NULL
egg	NULL
\\	NULL
;	NULL
\	NULL
'_CL_|	NULL
IL-10R	NULL
HEDGZ	NULL
Cells	NULL
y	NULL
Cells	NULL
Ant-Stats	NULL
JS	NULL
MWD	NULL
``	NULL
ek	NULL
SIE	NULL
SIFA	NULL
ppls	NULL
msoy-	NULL
+288	NULL
rANA	NULL
Sir	NULL
&	NULL
lighed	NULL
l	NULL
ASCE	NULL
IL-10R	NULL
mRNA	NULL
siFC	NULL
>	NULL
a	NULL
w	NULL
»	NULL
-sifc	NULL
IL~10R	NULL
mRNA	NULL
a=	NULL
-	NULL
C	NULL
S	NULL
TB-2	NULL
a	NULL
i	NULL
$	NULL
y	NULL
gh	NULL
i	NULL
lu	NULL
Northern	NULL
Blot	NULL
EtBr-Stain	NULL
®	NULL
gon	NULL
KQGNQQQ	NULL
|	NULL
g	NULL
~	NULL
\°Q.\§G	NULL
[	NULL
0	NULL
&	NULL
6	NULL
VS	NULL
o	NULL
LVKQ	NULL
&	NULL
®	NULL
B	NULL
IL~10	NULL
{	NULL
ng/m	NULL
!	NULL
)	NULL

IL-6	NULL
(	NULL
ng/ml	NULL
)	NULL
__	NULL
2	NULL
n	NULL
(	NULL
8	NULL
IL-10R-HepG2	NULL
Cells	NULL
E	NULL
ACH	NULL
IL-10	NULL
(	NULL
100	NULL
ng/ml	NULL
}	NULL
|	NULL
IL-6	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

8-	NULL
SIE	NULL
i-	NULL
SIF-A	NULL
~	NULL
but	NULL
6	NULL
4	NULL
.	NULL

6	NULL
shea	NULL
w	NULL
bu	NULL
w	NULL
we	NULL
:	NULL
:1	NULL
‘	NULL
Eg	NULL
E	NULL
SIF-C+	NULL
»	NULL
-	NULL
~	NULL
SIF-C	NULL
o	NULL
I	NULL
2	NULL
3	NULL
A\	NULL
A	NULL
TB-2	NULL
E	NULL
wah	NULL
E	NULL
HP	NULL
[	NULL
13442	NULL
]	NULL
1	NULL
[	NULL
63	NULL
]	NULL
6	NULL
]	NULL
00	NULL
}	NULL
$	NULL
1	NULL
e	NULL
s	NULL
a	NULL
f	NULL
fof	NULL
1	NULL
s	NULL
e	NULL
a	NULL
Length	NULL
of	NULL
Treatment	NULL
(	NULL
hours	NULL
)	NULL
on	NULL
€	NULL
.2	NULL
s	NULL
;	NULL
@	NULL
0-e	NULL
#	NULL
-	NULL
D	NULL
___	NULL
IL-10R-HepG2	NULL
Cells	NULL
HepG2	NULL
Cells	NULL
<	NULL
C	NULL
®	NULL
a	NULL
@	NULL
|_	NULL
so	NULL
F	NULL
<	NULL
#	NULL
#	NULL
-e	NULL
G	NULL
r	NULL
9	NULL
5	NULL
4	NULL
IL-10	NULL
05°	NULL
P	NULL
&	NULL
5	NULL
e	NULL
o	NULL
Agr	NULL
=	NULL
AGH	NULL
€	NULL
-	NULL
&	NULL
-	NULL
&	NULL
OB	NULL
i	NULL
*	NULL
HP	NULL
*C	NULL
C	NULL
sof	NULL
-	NULL
HP	NULL
6	NULL
L	NULL
L	NULL
L	NULL
.	NULL

-	NULL
AGP	NULL
|	NULL
AGP	NULL
®p	NULL
|	NULL
IL-6	NULL
mn	NULL
ACH	NULL
|	NULL
L	NULL
L	NULL
ACH	NULL
10-	NULL
L	NULL
L.	NULL
FB	NULL
|	NULL
FB	NULL
1c	NULL
1	NULL
I	NULL
1	NULL
1	NULL
1	NULL
I	NULL
1	NULL
1	NULL
0	NULL
0.01	NULL
0.4	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
0	NULL
0.01	NULL
.	NULL

04	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
Cytokine	NULL
Concentration	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Fic	NULL
.	NULL

6	NULL
.	NULL

IL-10R	NULL
activates	NULL
STAT3	NULL
and	NULL
stimulates	NULL
expression	NULL
of	NULL
endogenous	NULL
APP	NULL
genes	NULL
in	NULL
IL-10R-HepG2	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
total	NULL
cellular	NULL
RNAs	NULL
were	NULL
extracted	NULL
from	NULL
parental	NULL
HepG2	NULL
cells	NULL
,	NULL
IL-10R-HepG2	NULL
cells	NULL
,	NULL
and	NULL
B-CLL	NULL
cells	NULL
from	NULL
two	NULL
separate	NULL
patients	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
for	NULL
IL-10R	NULL
mRNA	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Equal	NULL
RNA	NULL
loading	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
ethidium	NULL
bromide	NULL
(	NULL
EtBr	NULL
)	NULL
staining	NULL
of	NULL
the	NULL
gel-separated	NULL
RNA	NULL
,	NULL
including	NULL
the	NULL
288	NULL
rRNA	NULL
band	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
IL-10R-HepG2	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
IL-6RE-CAT	NULL
.	NULL

Subcultures	NULL
were	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
the	NULL
cytokines	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

The	NULL
media	NULL
were	NULL
analyzed	NULL
by	NULL
immuncelectrophoresis	NULL
for	NULL
haptoglobin	NULL
and	NULL
a	NULL
;	NULL
-anti-chymotrypsin	NULL
using	NULL
a	NULL
mixture	NULL
of	NULL
the	NULL
respective	NULL
antibodies	NULL
(	NULL
upper	NULL
panel	NULL
!	NULL
)	NULL

.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
and	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
control-treated	NULL
cells	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

C	NULL
,	NULL
confluent	NULL
monolayers	NULL
of	NULL
IL-10R-HepG2	NULL
cells	NULL
in	NULL
six-well	NULL
cluster	NULL
plates	NULL
were	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
IL-10	NULL
or	NULL
IL-6	NULL
,	NULL
or	NULL
with	NULL
100	NULL
ng/m	NULL
!	NULL

cytokines	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
.	NULL

EMSA	NULL
pattern	NULL
with	NULL
SIE	NULL
and	NULL
TB-2	NULL
as	NULL
probes	NULL
were	NULL
prepared	NULL
.	NULL

Equal	NULL
aliquots	NULL
of	NULL
the	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
100	NULL
ng/ml	NULL
IL-10	NULL
or	NULL
IL-6	NULL
were	NULL
reacted	NULL
with	NULL
C20	NULL
anti-STAT3	NULL
antibodies	NULL
prior	NULL
to	NULL
EMSA	NULL
(	NULL
two	NULL
lanes	NULL
at	NULL
the	NULL
right	NULL
)	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
extracts	NULL
of	NULL
paternal	NULL
HepG2	NULL
cells	NULL
after	NULL
15	NULL
min	NULL
of	NULL
treatment	NULL
with	NULL
100	NULL
ng/ml	NULL
IL-10	NULL
or	NULL
IL-6	NULL
were	NULL
included	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
simultaneously	NULL
analyzed	NULL
.	NULL

The	NULL
autoradiographic	NULL
images	NULL
after	NULL
identical	NULL
exposure	NULL
time	NULL
(	NULL
6	NULL
h	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

D	NULL
,	NULL
confluent	NULL
monolayers	NULL
of	NULL
IL-10R-HepG2	NULL
cells	NULL
and	NULL
paternal	NULL
HepG2	NULL
cells	NULL
in	NULL
24-well	NULL
culture	NULL
plates	NULL
were	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
IL-10	NULL
or	NULL
IL-6	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
secreted	NULL
haptoglobin	NULL
(	NULL
HP	NULL
)	NULL
,	NULL
«	NULL
,	NULL
-acid	NULL
glycoprotein	NULL
(	NULL
AGP	NULL
)	NULL
,	NULL
«	NULL
,	NULL
-anti-chymotrypsin	NULL
(	NULL
ACH	NULL
)	NULL
,	NULL
and	NULL
fibrinogen	NULL
(	NULL
FB	NULL
)	NULL
were	NULL
determined	NULL
by	NULL
immuncelectrophoresis	NULL
and	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
control	NULL
treated	NULL
cultures	NULL
in	NULL
each	NULL
group	NULL
.	NULL

The	NULL
results	NULL
of	NULL
one	NULL
experimental	NULL
series	NULL
are	NULL
shown	NULL
.	NULL

Virtually	NULL
identical	NULL
relative	NULL
cytokine	NULL
responses	NULL
were	NULL
recorded	NULL
in	NULL
two	NULL
additional	NULL
,	NULL
independent	NULL
experimental	NULL
series	NULL
.	NULL

The	NULL
low	NULL
magnitude	NULL
of	NULL
fibrinogen	NULL
regulation	NULL
is	NULL
due	NULL
to	NULL
the	NULL
high	NULL
basal	NULL
level	NULL
production	NULL
of	NULL
that	NULL
protein	NULL
by	NULL
HepG2	NULL
cells	NULL
.	NULL

capable	NULL
of	NULL
activating	NULL
HRRE-CAT	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
5	NULL
;	NULL
Refs	NULL
.	NULL

15	NULL
,	NULL
16	NULL
,	NULL
exerted	NULL
a	NULL
dominant	NULL
negative	NULL
action	NULL
on	NULL
the	NULL
STAT5	NULL
pathway	NULL
21	NULL
,	NULL
and	NULL
23	NULL
)	NULL
.	NULL

This	NULL
signaling	NULL
appeared	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
IL-10R	NULL
nor	NULL
the	NULL
IL-6R	NULL
effect	NULL
on	NULL
STAT3	NULL
but	NULL
could	NULL
in	NULL
part	NULL
be	NULL
reproduced	NULL
by	NULL
activated	NULL
STAT5B	NULL
-	NULL
HRRE	NULL
was	NULL
significantly	NULL
impaired	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
induc-	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Although	NULL
IL-10R	NULL
failed	NULL
to	NULL
detectably	NULL
activate	NULL
overex-	NULL
tion	NULL
process	NULL
by	NULL
these	NULL
receptors	NULL
did	NULL
not	NULL
involve	NULL
STATS	NULL
as	NULL
a	NULL
pressed	NULL
STAT5B	NULL
in	NULL
COS-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
this	NULL
receptor	NULL
,	NULL
as	NULL
well	NULL
-	NULL
critical	NULL
mediator	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
regulatory	NULL
action	NULL
by	NULL
the	NULL
as	NULL
the	NULL
other	NULL
receptors	NULL
,	NULL
could	NULL
conceivably	NULL
engage	NULL
the	NULL
low	NULL
-	NULL
IL-3R	NULL
was	NULL
substantially	NULL
reduced	NULL
by	NULL
STAT5BA4OC	NULL
attested	NULL
to	NULL
a	NULL
amount	NULL
of	NULL
endogenous	NULL
STATS	NULL
in	NULL
HepG2	NULL
to	NULL
induce	NULL
HRRE-CAT	NULL
.	NULL

_-	NULL
contributing	NULL
role	NULL
of	NULL
STATS	NULL
to	NULL
the	NULL
high	NULL
activity	NULL
of	NULL
this	NULL
receptor	NULL
.	NULL

To	NULL
assess	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
introduced	NULL
STAT5BAA40C	NULL
that	NULL
,	NULL
by	NULL
IL-10R	NULL
Activates	NULL
Endogenous	NULL
APP	NULL
Gene-The	NULL
results	NULL
from	NULL
virtue	NULL
of	NULL
lacking	NULL
41	NULL
carboxyl-terminal	NULL
amino	NULL
acid	NULL
residues	NULL
(	NULL
22	NULL
)	NULL
,	NULL
the	NULL
transfection	NULL
experiments	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
indicated	NULL
that	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
13974	NULL
IL-10R	NULL
exerted	NULL
IL-6R-like	NULL
functions	NULL
.	NULL

We	NULL
expected	NULL
that	NULL
this	NULL
regulatory	NULL
effect	NULL
was	NULL
not	NULL
restricted	NULL
to	NULL
co-transfected	NULL
reporter	NULL
genes	NULL
but	NULL
also	NULL
applied	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
endogenous	NULL
IL-6-regulated	NULL
genes	NULL
.	NULL

The	NULL
transient	NULL
transfection	NULL
procedure	NULL
yielded	NULL
a	NULL
relatively	NULL
low	NULL
number	NULL
of	NULL
transfected	NULL
HepG2	NULL
cells	NULL
per	NULL
culture	NULL
(	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
rendered	NULL
the	NULL
analysis	NULL
of	NULL
IL-10R	NULL
effects	NULL
on	NULL
endogenous	NULL
genes	NULL
in	NULL
those	NULL
cells	NULL
impractical	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
generated	NULL
HepG2	NULL
cells	NULL
stably	NULL
expressing	NULL
the	NULL
IL-10R	NULL
by	NULL
applying	NULL
a	NULL
retroviral	NULL
vector	NULL
for	NULL
both	NULL
the	NULL
human	NULL
IL-10R	NULL
cDNA	NULL
and	NULL
neo	NULL
gene	NULL
.	NULL

After	NULL
4	NULL
weeks	NULL
of	NULL
selection	NULL
,	NULL
we	NULL
obtained	NULL
a	NULL
cell	NULL
population	NULL
(	NULL
termed	NULL
IL-10R-HepG2	NULL
cells	NULL
)	NULL
that	NULL
expressed	NULL
the	NULL
expected	NULL
4.5-kilobase	NULL
fusion	NULL
MSCV-IL-10R	NULL
mRNA	NULL
detectable	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
IL-10R	NULL
mRNA	NULL
appeared	NULL
to	NULL
be	NULL
in	NULL
the	NULL
range	NULL
of	NULL
that	NULL
detected	NULL
in	NULL
CLL-cells	NULL
.	NULL

Lacking	NULL
reagents	NULL
to	NULL
identify	NULL
IL-10R	NULL
protein	NULL
expression	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
presence	NULL
of	NULL
IL-10R	NULL
by	NULL
its	NULL
signaling	NULL
functions	NULL
that	NULL
were	NULL
predicted	NULL
from	NULL
the	NULL
transfection	NULL
experiments	NULL
.	NULL

First	NULL
,	NULL
we	NULL
transiently	NULL
introduced	NULL
the	NULL
IL-6RE-CAT	NULL
construct	NULL
into	NULL
IL-10R-HepG2	NULL
cells	NULL
and	NULL
compared	NULL
its	NULL
regulation	NULL
by	NULL
IL-10-	NULL
and	NULL
IL-6-type	NULL
cytokines	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

IL-10	NULL
stimulated	NULL
CAT	NULL
expression	NULL
to	NULL
a	NULL
level	NULL
close	NULL
to	NULL
that	NULL
of	NULL
IL-6	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
previously	NULL
reported	NULL
data	NULL
on	NULL
the	NULL
paternal	NULL
HepG2	NULL
cells	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
,	NULL
oncostatin	NULL
M	NULL
exerted	NULL
in	NULL
IL-10R-HepG2	NULL
cells	NULL
a	NULL
stimulation	NULL
of	NULL
the	NULL
CAT	NULL
expression	NULL
that	NULL
exceeded	NULL
the	NULL
IL-6	NULL
action	NULL
,	NULL
whereas	NULL
the	NULL
LIF	NULL
response	NULL
was	NULL
substantially	NULL
below	NULL
.	NULL

The	NULL
relative	NULL
inducing	NULL
effects	NULL
of	NULL
the	NULL
cytokines	NULL
on	NULL
the	NULL
transfected	NULL
CAT	NULL
gene	NULL
were	NULL
essentially	NULL
identical	NULL
to	NULL
those	NULL
on	NULL
the	NULL
endogenous	NULL
type	NULL
2	NULL
APPs	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
production	NULL
of	NULL
«	NULL
;	NULL
and	NULL
haptoglobin	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
similarity	NULL
of	NULL
receptor	NULL
action	NULL
at	NULL
the	NULL
level	NULL
of	NULL
STAT	NULL
activation	NULL
,	NULL
IL-10R-HepG2	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
treatment	NULL
with	NULL
increasing	NULL
cytokine	NULL
concentrations	NULL
or	NULL
for	NULL
increasing	NULL
lengths	NULL
of	NULL
time	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
EMSA	NULL
for	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
SIE	NULL
or	NULL
TB-2	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Maximal	NULL
response	NULL
was	NULL
observed	NULL
after	NULL
15	NULL
min	NULL
of	NULL
treatment	NULL
with	NULL
100	NULL
ng/ml	NULL
IL-10	NULL
.	NULL

Primarily	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
SIF-A	NULL
complex	NULL
by	NULL
IL-10	NULL
was	NULL
detected	NULL
,	NULL
and	NULL
this	NULL
complex	NULL
was	NULL
recognized	NULL
by	NULL
anti-STAT3	NULL
in	NULL
supershift	NULL
assay	NULL
.	NULL

The	NULL
time	NULL
course	NULL
of	NULL
STAT3	NULL
activation	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
mediated	NULL
by	NULL
IL-6	NULL
.	NULL

Peak	NULL
activity	NULL
was	NULL
measured	NULL
at	NULL
15	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
reduction	NULL
with	NULL
a	NULL
nadir	NULL
at	NULL
1	NULL
h	NULL
,	NULL
and	NULL
a	NULL
renewed	NULL
increase	NULL
to	NULL
submaximal	NULL
level	NULL
over	NULL
the	NULL
subsequent	NULL
24	NULL
h.	NULL
Notable	NULL
differences	NULL
between	NULL
IL-10	NULL
and	NULL
IL-6	NULL
were	NULL
that	NULL
IL-6	NULL
was	NULL
effective	NULL
at	NULL
10	NULL
times	NULL
lower	NULL
concentrations	NULL
,	NULL
was	NULL
capable	NULL
of	NULL
activating	NULL
STAT1	NULL
during	NULL
the	NULL
initial	NULL
30-min	NULL
treatment	NULL
period	NULL
,	NULL
and	NULL
activated	NULL
factors	NULL
that	NULL
together	NULL
with	NULL
STAT3	NULL
contributed	NULL
to	NULL
the	NULL
observed	NULL
TB-2	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Although	NULL
IL-10R	NULL
HepG2	NULL
cells	NULL
are	NULL
phenotypically	NULL
different	NULL
from	NULL
leukocytes	NULL
,	NULL
the	NULL
patterns	NULL
of	NULL
STAT	NULL
protein	NULL
activation	NULL
by	NULL
the	NULL
IL-10R	NULL
and	NULL
IL-6R	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
show	NULL
remarkable	NULL
resemblance	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

6C	NULL
with	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
similarity	NULL
of	NULL
IL-10	NULL
and	NULL
IL-6	NULL
action	NULL
also	NULL
applied	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
endogenous	NULL
genes	NULL
in	NULL
IL-10R-HepG2	NULL
cells	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
cytokine	NULL
dose-dependent	NULL
stimulation	NULL
of	NULL
APP	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

We	NULL
selected	NULL
a	NULL
,	NULL
-anti-chymotrypsin	NULL
,	NULL
haptoglobin	NULL
,	NULL
a	NULL
,	NULL
-acid	NULL
glycoprotein	NULL
,	NULL
and	NULL
fibrinogen	NULL
as	NULL
representative	NULL
markers	NULL
.	NULL

IL-10	NULL
increased	NULL
all	NULL
four	NULL
proteins	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

Although	NULL
the	NULL
maximal	NULL
production	NULL
levels	NULL
attained	NULL
were	NULL
below	NULL
those	NULL
stimulated	NULL
by	NULL
IL-6	NULL
,	NULL
the	NULL
relative	NULL
effects	NULL
of	NULL
the	NULL
two	NULL
cytokines	NULL
on	NULL
these	NULL
gene	NULL
products	NULL
were	NULL
strikingly	NULL
similar	NULL
.	NULL

The	NULL
dose	NULL
response	NULL
indicated	NULL
that	NULL
half-maximal	NULL
stimulation	NULL
of	NULL
the	NULL
APPs	NULL
was	NULL
achieved	NULL
with	NULL
2-5	NULL
ng/ml	NULL
IL-10	NULL
and	NULL
with	NULL
0.5-2	NULL
ng/ml	NULL
IL-6	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
APPs	NULL
proved	NULL
to	NULL
be	NULL
essentially	NULL
indistinguishable	NULL
from	NULL
the	NULL
paternal	NULL
HepG2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
retroviral	NULL
infection	NULL
,	NULL
selection	NULL
in	NULL
G418	NULL
,	NULL
and	NULL
IL-10R	NULL
expression	NULL
did	NULL
not	NULL
detectably	NULL
modify	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
HepG2	NULL
cell	NULL
population	NULL
.	NULL

IL-10	NULL
Receptor	NULL
Signaling	NULL
I-6RE-CAT	NULL
B	NULL
30	NULL
C	NULL
3	NULL
20	NULL
S	NULL
3	NULL
10	NULL
€	NULL
,	NULL
&	NULL
HRRE-CAT	NULL
T	NULL
10	NULL
©	NULL
LL	NULL
5	NULL
M	NULL
CG	NULL
<	NULL
+	NULL
SIF-A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
607	NULL
i	NULL
®	NULL
9	NULL
9	NULL
@	NULL
8	NULL
-	NULL
.2	NULL
$	NULL
.	NULL

P	NULL
$	NULL
&	NULL
$	NULL
S	NULL
.	NULL

$	NULL
&	NULL
ay	NULL
bs	NULL
F	NULL
.	NULL

$	NULL
Q0	NULL
V	NULL
vo	NULL
V	NULL
Y	NULL
+	NULL
pSV-STAT3	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Box	NULL
3-containing	NULL
region	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
IL-10R	NULL
signaling	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
presentation	NULL
of	NULL
the	NULL
mouse	NULL
IL-10R	NULL
with	NULL
progressive	NULL
carboxyl-terminal	NULL
truncations	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

11	NULL
)	NULL
used	NULL
for	NULL
transfection	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
4	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
HepG2	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
IL-10R	NULL
forms	NULL
shown	NULL
in	NULL
A	NULL
,	NULL
together	NULL
with	NULL
either	NULL
IL-6RE-CAT	NULL
or	NULL
HRRE-CAT	NULL
.	NULL

For	NULL
each	NULL
receptor	NULL
transfection	NULL
,	NULL
the	NULL
fold-stimulation	NULL
of	NULL
the	NULL
reporter	NULL
construct	NULL
by	NULL
IL-10	NULL
treatment	NULL
was	NULL
calculated	NULL
.	NULL

C	NULL
,	NULL
the	NULL
indicated	NULL
IL-10R	NULL
forms	NULL
were	NULL
transfected	NULL
without	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
with	NULL
expression	NULL
vector	NULL
for	NULL
STAT3	NULL
(	NULL
Zanes	NULL
3-7	NULL
)	NULL
into	NULL
COS-1	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
in	NULL
lane	NULL
I	NULL
were	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
medium	NULL
alone	NULL
and	NULL
those	NULL
in	NULL
Zanes	NULL
2-7	NULL
with	NULL
medium	NULL
and	NULL
IL-10	NULL
.	NULL

SIE	NULL
binding	NULL
activities	NULL
in	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

Signaling	NULL
Functions	NULL
of	NULL
the	NULL
IL-10R	NULL
Requires	NULL
the	NULL
Presence	NULL
of	NULL
the	NULL
Box	NULL
3	NULL
Motifs-The	NULL
comparative	NULL
analyses	NULL
of	NULL
leukocytes	NULL
and	NULL
transfected	NULL
cells	NULL
suggested	NULL
that	NULL
the	NULL
IL-10R	NULL
and	NULL
IL-6R	NULL
engage	NULL
common	NULL
intracellular	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

The	NULL
IL-6R-like	NULL
action	NULL
of	NULL
the	NULL
IL-10R	NULL
,	NULL
in	NULL
particular	NULL
the	NULL
activation	NULL
of	NULL
STAT3	NULL
and	NULL
induction	NULL
of	NULL
IL-6RE-containing	NULL
genes	NULL
,	NULL
was	NULL
believed	NULL
to	NULL
be	NULL
dependent	NULL
upon	NULL
the	NULL
box	NULL
3	NULL
motifs	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

By	NULL
applying	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
mouse	NULL
IL-10R	NULL
,	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
had	NULL
already	NULL
shown	NULL
that	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
containing	NULL
the	NULL
two	NULL
box	NULL
3	NULL
sequences	NULL
is	NULL
critical	NULL
for	NULL
regulating	NULL
differentiated	NULL
cell	NULL
function	NULL
in	NULL
the	NULL
pre	NULL
B-cell	NULL
line	NULL
Ba/F3	NULL
.	NULL

We	NULL
utilized	NULL
the	NULL
same	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
mouse	NULL
IL-10R	NULL
with	NULL
progressive	NULL
carboxyl-terminal	NULL
deletions	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
for	NULL
testing	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
receptor	NULL
forms	NULL
to	NULL
induce	NULL
IL-6RE	NULL
and	NULL
HRRE-CAT	NULL
gene	NULL
expression	NULL
in	NULL
transfected	NULL
HepG2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

73	NULL
)	NULL
and	NULL
to	NULL
activate	NULL
STAT3	NULL
in	NULL
COS-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Ho	NULL
et	NULL
al	NULL
.	NULL

had	NULL
established	NULL
that	NULL
each	NULL
expression	NULL
vector	NULL
directed	NULL
the	NULL
synthesis	NULL
and	NULL
surface	NULL
display	NULL
of	NULL
the	NULL
comparable	NULL
levels	NULL
of	NULL
IL-10R	NULL
molecules	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
region	NULL
with	NULL
both	NULL
box	NULL
3	NULL
motifs	NULL
was	NULL
required	NULL
for	NULL
full	NULL
IL-10R	NULL
signaling	NULL
in	NULL
both	NULL
cell	NULL
systems	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
distal	NULL
box	NULL
3	NULL
(	NULL
A433-559	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
drastic	NULL
loss	NULL
of	NULL
gene	NULL
induction	NULL
and	NULL
in	NULL
a	NULL
reduced	NULL
STAT3	NULL
activation	NULL
.	NULL

Truncation	NULL
past	NULL
the	NULL
proximal	NULL
box	NULL
3	NULL
motif	NULL
(	NULL
A402-559	NULL
)	NULL
eliminated	NULL
all	NULL
signaling	NULL
activity	NULL
.	NULL

These	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
IL-10	NULL
Receptor	NULL
Signaling	NULL
results	NULL
highlighted	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
and	NULL
gene	NULL
induction	NULL
in	NULL
our	NULL
cell	NULL
systems	NULL
followed	NULL
the	NULL
specificity	NULL
of	NULL
IL-10R	NULL
action	NULL
as	NULL
defined	NULL
by	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

in	NULL
Ba/F3	NULL
cells	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
cell	NULL
surface	NULL
markers	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
in	NULL
Ref	NULL
.	NULL

11	NULL
)	NULL
.	NULL

The	NULL
similarity	NULL
suggested	NULL
that	NULL
the	NULL
box	NULL
3-containing	NULL
region	NULL
of	NULL
the	NULL
IL-10R	NULL
probably	NULL
exerts	NULL
equivalent	NULL
functions	NULL
in	NULL
these	NULL
distinct	NULL
cell	NULL
types	NULL
and	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
STAT3	NULL
is	NULL
one	NULL
of	NULL
the	NULL
common	NULL
processes	NULL
.	NULL

The	NULL
results	NULL
of	NULL
Fig	NULL
.	NULL

7	NULL
also	NULL
revealed	NULL
a	NULL
significant	NULL
difference	NULL
between	NULL
the	NULL
IL-10R	NULL
and	NULL
hematopoietin	NULL
receptors	NULL
such	NULL
as	NULL
gp130	NULL
or	NULL
G-CSFR	NULL
.	NULL

The	NULL
membrane-proximal	NULL
and	NULL
box	NULL
3-deficient	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
IL-10R	NULL
(	NULL
as	NULL
present	NULL
in	NULL
A402-559	NULL
)	NULL
was	NULL
unable	NULL
to	NULL
trigger	NULL
an	NULL
induction	NULL
of	NULL
the	NULL
HRRE-CAT	NULL
construct	NULL
,	NULL
whereas	NULL
the	NULL
corresponding	NULL
membrane	NULL
proximal	NULL
domain	NULL
of	NULL
the	NULL
G-CSFR	NULL
on	NULL
gp130	NULL
(	NULL
containing	NULL
only	NULL
box	NULL
1	NULL
and	NULL
2	NULL
motifs	NULL
)	NULL
,	NULL
while	NULL
ineffective	NULL
toward	NULL
IL-6RE-CAT	NULL
gene	NULL
could	NULL
still	NULL
mediate	NULL
a	NULL
maximal	NULL
induction	NULL
of	NULL
the	NULL
HRRE-CAT	NULL
gene	NULL
(	NULL
15	NULL
)	NULL
.	NULL

We	NULL
concluded	NULL
from	NULL
this	NULL
observation	NULL
that	NULL
the	NULL
IL-10R	NULL
must	NULL
accomplish	NULL
initiation	NULL
of	NULL
signaling	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
is	NULL
not	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
gp130	NULL
.	NULL

The	NULL
signaling	NULL
by	NULL
both	NULL
receptors	NULL
,	NULL
however	NULL
,	NULL
converge	NULL
onto	NULL
common	NULL
signal	NULL
transducing	NULL
molecules	NULL
and	NULL
identical	NULL
genetic	NULL
targets	NULL
.	NULL

The	NULL
precise	NULL
enzymatic	NULL
processes	NULL
that	NULL
underlie	NULL
these	NULL
regulatory	NULL
pathways	NULL
remains	NULL
to	NULL
be	NULL
fully	NULL
characterized	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Figs	NULL
.	NULL

4-7	NULL
)	NULL
demonstrate	NULL
that	NULL
the	NULL
transcription-inducing	NULL
action	NULL
of	NULL
IL-10R	NULL
is	NULL
similar	NULL
to	NULL
IL-6-type	NULL
cytokines	NULL
but	NULL
is	NULL
clearly	NULL
different	NULL
from	NULL
IFN	NULL
«	NULL
/B	NULL
or	NULL
IFNy	NULL
(	NULL
86	NULL
,	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Ectopically	NULL
expressed	NULL
IL-10R	NULL
,	NULL
like	NULL
hematopoietin	NULL
receptors	NULL
,	NULL
promoted	NULL
proliferation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
11	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
differentiated	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
IL-10R	NULL
function	NULL
has	NULL
traditionally	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
anti-inflamma-tory	NULL
by	NULL
virtue	NULL
of	NULL
suppressing	NULL
expression	NULL
of	NULL
genes	NULL
for	NULL
cytokines	NULL
(	NULL
13	NULL
,	NULL
47	NULL
,	NULL
48	NULL
)	NULL
or	NULL
nitric-oxide	NULL
synthetase	NULL
(	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IL-10	NULL
has	NULL
also	NULL
been	NULL
noted	NULL
to	NULL
induce	NULL
gene	NULL
expression	NULL
such	NULL
as	NULL
arginase	NULL
in	NULL
macrophages	NULL
(	NULL
50	NULL
)	NULL
or	NULL
enhance	NULL
immunoglobulin	NULL
expression	NULL
in	NULL
IL-2-treated	NULL
B	NULL
cells	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
mode	NULL
of	NULL
IL-10R	NULL
signaling	NULL
may	NULL
follow	NULL
the	NULL
IL-6R-like	NULL
mechanisms	NULL
that	NULL
we	NULL
have	NULL
defined	NULL
in	NULL
HepG2	NULL
cells	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
would	NULL
also	NULL
predict	NULL
that	NULL
IL-6	NULL
will	NULL
act	NULL
like	NULL
IL-10	NULL
in	NULL
B-cells	NULL
,	NULL
e.g	NULL
.	NULL

by	NULL
activating	NULL
some	NULL
STAT	NULL
proteins	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
similar	NULL
effects	NULL
of	NULL
IL-6	NULL
and	NULL
IL-10	NULL
have	NULL
been	NULL
noted	NULL
,	NULL
the	NULL
mode	NULL
of	NULL
action	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
identical	NULL
,	NULL
such	NULL
as	NULL
in	NULL
CD4O-activated	NULL
B-CLL	NULL
cells	NULL
(	NULL
52	NULL
)	NULL
or	NULL
in	NULL
myeloma	NULL
cells	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
greatly	NULL
indebted	NULL
to	NULL
Immunex	NULL
Corp.	NULL
,	NULL
Genetics	NULL
Institute	NULL
,	NULL
Genentech	NULL
,	NULL
and	NULL
Sandoz	NULL
for	NULL
the	NULL
generous	NULL
supply	NULL
of	NULL
cytokines	NULL
,	NULL
and	NULL
to	NULL
Dr.	NULL
Kevin	NULL
W.	NULL
Moore	NULL
for	NULL
providing	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IL-10R	NULL
expression	NULL
vectors	NULL
that	NULL
made	NULL
this	NULL
study	NULL
possible	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Gennaro	NULL
Ciliberto	NULL
for	NULL
pCRP	NULL
(	NULL
219	NULL
)	NULL
-CAT	NULL
,	NULL
Dr.	NULL
Hans	NULL
G.	NULL
Klingermann	NULL
for	NULL
NK-92	NULL
cells	NULL
,	NULL
Yanping	NULL
Wang	NULL
and	NULL
A	NULL
.	NULL

Z.	NULL
C.	NULL
Fong	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Marcia	NULL
Held	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
.	NULL

Belardelli	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Acta	NULL
Path	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

Scand	NULL
.	NULL

108	NULL
,	NULL
161-179	NULL
.	NULL

Biron	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
530-538	NULL
.	NULL

Ho	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
,	NULL
Khan	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Hsu	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Bazan	NULL
,	NULL
J.	NULL
F.	NULL
&	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11267-11271	NULL
4	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
,	NULL
Wei	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
de	NULL
Wassl	NULL
Malefyt	NULL
,	NULL
R.	NULL
&	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
1821-1829	NULL
5	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
&	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
428-432	NULL
6	NULL
.	NULL

Tan	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Braun	NULL
,	NULL
S.	NULL
,	NULL
Rong	NULL
,	NULL
H.	NULL
,	NULL
DiGiacomo	NULL
,	NULL
R.	NULL
,	NULL
Dolphin	NULL
,	NULL
E.	NULL
,	NULL
Baldwin	NULL
,	NULL
S.	NULL
,	NULL
Narula	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Zavodny	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

&	NULL
Chou	NULL
,	NULL
C.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
12906-12911	NULL
7	NULL
.	NULL

Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Webb	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Sweitzer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1730-1733	NULL
8	NULL
.	NULL

Weber-Nordt	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Meraz	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
co	NULL
bo	NULL
|	NULL
10.	NULL
.	NULL

Ho	NULL
,	NULL
A	NULL
.	NULL

S.-Y	NULL
.	NULL

,	NULL
Wei	NULL
,	NULL
S	NULL
.	NULL

H.-Y	NULL
.	NULL

,	NULL
Mui	NULL
,	NULL
L.-F.	NULL
,	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

183975	NULL
3734-3744	NULL
.	NULL

Lehmann	NULL
,	NULL
J.	NULL
,	NULL
Seegert	NULL
,	NULL
D.	NULL
,	NULL
Strehlow	NULL
,	NULL
I.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Lohmann-Matthes	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Decker	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
165-172	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
&	NULL
Winestock	NULL
,	NULL
K.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
1079-1090	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
5043-5053	NULL
Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
Wang	NULL
,	NULL
P.	NULL
,	NULL
Wu	NULL
,	NULL
P.	NULL
,	NULL
Siegel	NULL
,	NULL
M.	NULL
,	NULL
Egan	NULL
,	NULL
R.	NULL
W.	NULL
&	NULL
Billah	NULL
,	NULL
N.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
9558-9563	NULL
Niiro	NULL
,	NULL
H.	NULL
,	NULL
Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Tanabe	NULL
,	NULL
T.	NULL
,	NULL
Hara	NULL
,	NULL
S.	NULL
,	NULL
Kuga	NULL
,	NULL
S.	NULL
,	NULL
Nemoto	NULL
,	NULL
Y.	NULL
,	NULL
Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Nakashima	NULL
,	NULL
H.	NULL
,	NULL
Kitajima	NULL
,	NULL
S.	NULL
,	NULL
Abe	NULL
,	NULL
M.	NULL
&	NULL
Niko	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
3736-3745	NULL
Lai	NULL
,	NULL
C.-F.	NULL
,	NULL
Ripperger	NULL
,	NULL
J.	NULL
,	NULL
Morella	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Wang	NULL
,	NULL
Y.	NULL
,	NULL
Gearing	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
&	NULL
Baumann	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
14847-14850	NULL
Morella	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Lai	NULL
,	NULL
C.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
Kumaki	NULL
,	NULL
N.	NULL
,	NULL
Wang	NULL
,	NULL
Y.	NULL
,	NULL
Bluman	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Giri	NULL
,	NULL
J.	NULL
,	NULL
Gearing	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
Ziegler	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Tweardy	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Campos	NULL
,	NULL
S.	NULL
P.	NULL
&	NULL
Baumann	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
8298-8310	NULL
Matos	NULL
,	NULL
M.	NULL
,	NULL
Schnier	NULL
,	NULL
G.	NULL
,	NULL
Beecher	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Ashman	NULL
,	NULL
L.	NULL
,	NULL
Williams	NULL
,	NULL
D.	NULL
&	NULL
Caligiuri	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1079-1084	NULL
Larsen	NULL
,	NULL
A.	NULL
,	NULL
Davis	NULL
,	NULL
T.	NULL
,	NULL
Curtis	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Gimpel	NULL
,	NULL
S.	NULL
,	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
Park	NULL
,	NULL
L.	NULL
,	NULL
Sorensen	NULL
,	NULL
E.	NULL
,	NULL
Mach	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

&	NULL
Smith	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
,	NULL
1559-1570	NULL
Hayashida	NULL
,	NULL
K.	NULL
,	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Gorman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
&	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9655-9659	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Sato	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
1165-1174	NULL
Wang	NULL
,	NULL
Y.	NULL
,	NULL
Morella	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Ripperger	NULL
,	NULL
J.	NULL
,	NULL
Lai	NULL
,	NULL
C.-F.	NULL
,	NULL
Gearing	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Campos	NULL
,	NULL
S.	NULL
P.	NULL
&	NULL
Baumann	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
1671-1679	NULL
Ripperger	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Fritz	NULL
,	NULL
S.	NULL
,	NULL
Richter	NULL
,	NULL
K.	NULL
,	NULL
Hocke	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Lottspeich	NULL
,	NULL
T.	NULL
&	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
29998-30006	NULL
Lai	NULL
,	NULL
C.-F.	NULL
,	NULL
Ripperger	NULL
,	NULL
J.	NULL
,	NULL
Morella	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Wang	NULL
,	NULL
Y.	NULL
,	NULL
Gearing	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Horseman	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Campos	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
&	NULL
Baumann	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
23254-23257	NULL
Northemann	NULL
,	NULL
W.	NULL
,	NULL
Shiels	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Braciak	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Hanson	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Biochemistry	NULL
27	NULL
,	NULL
9194-9208	NULL
Kordula	NULL
,	NULL
T.	NULL
&	NULL
Travis	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

818	NULL
,	NULL
1019-1027	NULL
Ganter	NULL
,	NULL
U.	NULL
,	NULL
Arcone	NULL
,	NULL
R.	NULL
,	NULL
Toniatti	NULL
,	NULL
C.	NULL
,	NULL
Morrone	NULL
,	NULL
G.	NULL
&	NULL
Ciliberto	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
3773-3779	NULL
Lopata	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Cleveland	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Sollner-Webb	NULL
,	NULL
H.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
5707-5717	NULL
Graham	NULL
,	NULL
F.	NULL
L.	NULL
&	NULL
Van	NULL
der	NULL
Eb	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
19783	NULL
)	NULL
Virology	NULL
52	NULL
,	NULL
456-461	NULL
Hawley	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Lieu	NULL
,	NULL
F.	NULL
H.	NULL
L.	NULL
,	NULL
Fong	NULL
,	NULL
A	NULL
.	NULL

Z.	NULL
C.	NULL
&	NULL
Hawley	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Gene	NULL
Ther	NULL
.	NULL

1	NULL
,	NULL
136-138	NULL
Miller	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Buttimore	NULL
,	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
2895-2902	NULL
Hawley	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Fong	NULL
,	NULL
A	NULL
.	NULL

Z.	NULL
C.	NULL
,	NULL
Ngan	NULL
,	NULL
B.-Y	NULL
.	NULL

&	NULL
Hawley	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
1113-1123	NULL
Markowitz	NULL
,	NULL
D.	NULL
,	NULL
Goff	NULL
,	NULL
S.	NULL
&	NULL
Bank	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
1120-1124	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
&	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
26	NULL
,	NULL
1739-1744	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
&	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Brechner	NULL
,	NULL
T.	NULL
,	NULL
Hocke	NULL
,	NULL
G.	NULL
,	NULL
Goel	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

&	NULL
Med	NULL
.	NULL

8	NULL
,	NULL
267-285	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
Farruggella	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
&	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1349-1353	NULL
Jurlander	NULL
,	NULL
J.	NULL
,	NULL
Lai	NULL
,	NULL
C.-F.	NULL
,	NULL
Tan	NULL
,	NULL
J.	NULL
,	NULL
Chou	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Geisler	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Narula	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Baumann	NULL
,	NULL
H.	NULL
&	NULL
Caligiuri	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
(	NULL
suppl	NULL
.	NULL
)	NULL

,	NULL
1371	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Horvath	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
L.	NULL
H.	NULL
T.	NULL
,	NULL
Qureshi	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Cowburn	NULL
,	NULL
D.	NULL
&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
821-828	NULL
Hiraoka	NULL
,	NULL
O.	NULL
,	NULL
Anaguchi	NULL
,	NULL
H.	NULL
,	NULL
Asakura	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Ota	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
25928-25934	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
251-256	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
877	NULL
,	NULL
591-594	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
&	NULL
Taga	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
1243-1254	NULL
Lamb	NULL
,	NULL
P.	NULL
,	NULL
Seidel	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Haslam	NULL
,	NULL
J.	NULL
,	NULL
Milocco	NULL
,	NULL
L.	NULL
,	NULL
Kessler	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

&	NULL
Rosen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

28	NULL
,	NULL
3283-3289	NULL
Kordula	NULL
,	NULL
T.	NULL
,	NULL
Ripperger	NULL
,	NULL
J.	NULL
,	NULL
Morella	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Travis	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Baumann	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
6752-6757	NULL
Richards	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Shoyab	NULL
,	NULL
M.	NULL
,	NULL
Baumann	NULL
,	NULL
H.	NULL
&	NULL
Gauldie	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1731-1736	NULL
Baumann	NULL
,	NULL
H.	NULL
&	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1163-1167	NULL
Berg	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Leach	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Kuhn	NULL
,	NULL
R.	NULL
,	NULL
Rajewsky	NULL
,	NULL
K.	NULL
,	NULL
Muller	NULL
,	NULL
W.	NULL
,	NULL
Davidson	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
&	NULL
Rennick	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182	NULL
,	NULL
99-108	NULL
Hart	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Jones	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Finlay-Jones	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57	NULL
,	NULL
909-918	NULL
Liew	NULL
,	NULL
F.	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Lett	NULL
.	NULL

48	NULL
,	NULL
95-98	NULL
Corraliza	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Soler	NULL
,	NULL
G.	NULL
,	NULL
Eichmann	NULL
,	NULL
K.	NULL
&	NULL
Modolell	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

206	NULL
,	NULL
667-673	NULL
Nonoyama	NULL
,	NULL
S.	NULL
,	NULL
Farrington	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Ochs	NULL
,	NULL
H.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immu-nopathol	NULL
.	NULL

72	NULL
,	NULL
373-379	NULL
Burdin	NULL
,	NULL
N.	NULL
,	NULL
Van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
Galibert	NULL
,	NULL
L.	NULL
,	NULL
Abrams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Wijdenes	NULL
,	NULL
J.	NULL
,	NULL
Banchereau	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Rousset	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
2533-2544	NULL
Lichtenstein	NULL
,	NULL
A.	NULL
,	NULL
Tu	NULL
,	NULL
Y.	NULL
,	NULL
Fady	NULL
,	NULL
C.	NULL
,	NULL
Vescio	NULL
,	NULL
R.	NULL
&	NULL
Berenson	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

162	NULL
,	NULL
248-255	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Receptors	NULL
for	NULL
Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
and	NULL
IL-6-type	NULL
Cytokines	NULL
Use	NULL
Similar	NULL
Signaling	NULL
Mechanisms	NULL
for	NULL
Inducing	NULL
Transcription	NULL
through	NULL
IL-6	NULL
Response	NULL
Elements	NULL
Chun-Fai	NULL
Lai	NULL
,	NULL
Juergen	NULL
Ripperger	NULL
,	NULL
Karen	NULL
K.	NULL
Morella	NULL
,	NULL
Jesper	NULL
Jurlander	NULL
,	NULL
Teresa	NULL
S.	NULL
Hawley	NULL
,	NULL
William	NULL
E.	NULL
Carson	NULL
,	NULL
Tomasz	NULL
Kordula	NULL
,	NULL
Michael	NULL
A.	NULL
Caligiuri	NULL
,	NULL
Robert	NULL
G.	NULL
Hawley	NULL
,	NULL
Georg	NULL
H.	NULL
Fey	NULL
and	NULL
Heinz	NULL
Baumann	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:13968-13975.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.24.13968	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/24/1	NULL
3968	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
53	NULL
references	NULL
,	NULL
31	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
3968.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

